| 1 |
Pereira MA, Dias AR, Ramos MFKP, Cardili L, Moraes RDR, Zilberstein B, Nahas SC, Mello ES, Ribeiro U. Gastric cancer with microsatellite instability displays increased thymidylate synthase expression. Journal of Surgical Oncology 2022;126:116-124. [DOI: 10.1002/jso.26822] [Reference Citation Analysis]
|
| 2 |
Kari S, Subramanian K, Altomonte IA, Murugesan A, Yli-Harja O, Kandhavelu M. Programmed cell death detection methods: a systematic review and a categorical comparison. Apoptosis 2022. [PMID: 35713779 DOI: 10.1007/s10495-022-01735-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Zhang SX, Tian W, Liu YL, Ni JH, Zhang D, Pan HF, Zhao ZM, Ai B, Chen ZS, Lin LZ, Liu W. Mechanism of N-Methyl-N-Nitroso-Urea-Induced Gastric Precancerous Lesions in Mice. J Oncol 2022;2022:3780854. [PMID: 35342404 DOI: 10.1155/2022/3780854] [Reference Citation Analysis]
|
| 4 |
He K, Chen C, Xia L, Si L, Pan X, Sun Z, Wang Y, Jiang Y, Shi Y, Zhou B, Wang S, Han J, Shen B, Zhou G, Lu J, Wang X. Deep muscularis propria tumor invasion without lymph node metastasis as a unique subclassification of stage IB gastric cancer: a retrospective study. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-021-02090-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Kim KW, Kim N, Choi Y, Kim WS, Yoon H, Shin CM, Park YS, Lee DH, Park YS, Ahn SH, Park DJ, Kim HH, Lee HS, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH. Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study. Gastric Cancer 2021;24:844-57. [PMID: 33598811 DOI: 10.1007/s10120-021-01163-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 6 |
Ziranu P, Lai E, Schirripa M, Puzzoni M, Persano M, Pretta A, Munari G, Liscia N, Pusceddu V, Loupakis F, Demurtas L, Libertini M, Mariani S, Migliari M, Dubois M, Giampieri R, Sotgiu G, Dei Tos AP, Lonardi S, Zaniboni A, Fassan M, Scartozzi M. The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment. Target Oncol 2021;16:517-27. [PMID: 33970400 DOI: 10.1007/s11523-021-00816-3] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Santos LL, Santos J, Gouveia MJ, Bernardo C, Lopes C, Rinaldi G, Brindley PJ, Costa JMCD. Urogenital Schistosomiasis-History, Pathogenesis, and Bladder Cancer. J Clin Med 2021;10:E205. [PMID: 33429985 DOI: 10.3390/jcm10020205] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 8 |
Koyama K, Maeda D, Kito M, Tamura D, Kudo-Asabe Y, Katoh H, Ishikawa S, Nanjo H, Terada Y, Goto A. Clinicopathological and molecular analyses of linearly expanded epithelial cells with β-catenin alterations, "β-catenin signature", in the normal fallopian tube. Histopathology 2020;77:880-9. [PMID: 32757328 DOI: 10.1111/his.14227] [Reference Citation Analysis]
|
| 9 |
Yao C, Wang X, Zhou Y, Jin X, Song L, Hu Y, Zeng W. Thermogravimetric analysis and kinetics characteristics of typical grains. J Therm Anal Calorim 2021;143:647-59. [DOI: 10.1007/s10973-019-09213-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 10 |
Moon WK, Chen HH, Shin SU, Han W, Chang RF. Evaluation of TP53/PIK3CA mutations using texture and morphology analysis on breast MRI. Magn Reson Imaging 2019;63:60-9. [PMID: 31425802 DOI: 10.1016/j.mri.2019.08.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Karner KH, Kohan JL, Tripp SR, Salama ME. Characterization of myeloid malignancies with TP53 mutations and comparison to P53 expression by immunohistochemical staining methods. Int J Lab Hematol 2020;42:e35-7. [PMID: 31390152 DOI: 10.1111/ijlh.13088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 12 |
Siegelmann-danieli N, Ben-lzhack O, Hanlon A, Ridge JA, Stein ME, Khandelwal V, Langer CJ. P53 Alteration in Oral Tongue Cancer is Not Significantly Associated with Age at Diagnosis or Tobacco Exposure. Tumori 2005;91:346-50. [DOI: 10.1177/030089160509100412] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 13 |
Xu JZ, Wang WQ, Zhang WH, Xu HX, Gao HL, Zhang SR, Wu CT, Li S, Li H, Xu J, Yu XJ, Liu L. The Loss of SMAD4/DPC4 Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer. J Cancer 2019;10:4123-31. [PMID: 31417657 DOI: 10.7150/jca.30883] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Renzi A, De Bonis P, Morandi L, Lenzi J, Tinto D, Rigillo A, Bettini G, Bellei E, Sabattini S. Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa. PLoS One 2019;14:e0215621. [PMID: 30998743 DOI: 10.1371/journal.pone.0215621] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 15 |
Nikolova D, Chalovska-Ivanova V, Genadieva-Dimitrova M, Eftimov A, Jovanovik R, Janevska V. TP53 Mutation in Correlation to Immunohistochemical Expression of P53 Protein in Patients with Hepatocellular Carcinoma. Open Access Maced J Med Sci 2018;6:1181-6. [PMID: 30087719 DOI: 10.3889/oamjms.2018.278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 16 |
Miyazaki T, Aishima S, Fujino M, Ozono K, Kubo Y, Ushijima Y, Osoegawa T, Ihara E, Tetsuhide I, Ohtsuka T, Nakamura M, Oda Y. Neuroendocrine tumor of the pancreas with rhabdoid feature. Virchows Arch 2018;473:247-52. [PMID: 29938394 DOI: 10.1007/s00428-018-2398-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 17 |
Niinuma T, Suzuki H, Sugai T. Molecular characterization and pathogenesis of gastrointestinal stromal tumor. Transl Gastroenterol Hepatol 2018;3:2. [PMID: 29441367 DOI: 10.21037/tgh.2018.01.02] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 18 |
Wang Y, Pascal LE, Zhong M, Ai J, Wang D, Jing Y, Pilch J, Song Q, Rigatti LH, Graham LE, Nelson JB, Parwani AV, Wang Z. Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice. Endocrinology 2017;158:4189-205. [PMID: 29029019 DOI: 10.1210/en.2017-00409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 19 |
Lu X, Yu Y, Tan S. p53 expression in patients with ulcerative colitis - associated with dysplasia and carcinoma: a systematic meta-analysis. BMC Gastroenterol 2017;17:111. [PMID: 29070013 DOI: 10.1186/s12876-017-0665-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Wu J, Guo A, Li Q, Wang D. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma. Future Oncol 2017;13:1883-91. [PMID: 28766969 DOI: 10.2217/fon-2017-0180] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 21 |
Wang H, Jin S, Lu H, Mi S, Shao W, Zuo X, Yin H, Zeng S, Shimamoto F, Qi G. Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics. Oncol Lett 2017;14:1011-6. [PMID: 28693267 DOI: 10.3892/ol.2017.6218] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 22 |
Fatemeh M, Sepideh A, Sara BS, Nazanin M. P53 Protein Expression in Dental Follicle, Dentigerous Cyst, Odontogenic Keratocyst, and Inflammatory Subtypes of Cysts: An Immunohistochemical Study. Oman Med J 2017;32:227-32. [PMID: 28584604 DOI: 10.5001/omj.2017.42] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 23 |
Wang X, Lv W, Qi F, Gao Z, Yang H, Wang W, Gao Y. Clinical effects of p53 overexpression in squamous cell carcinoma of the sinonasal tract: A systematic meta-analysis with PRISMA guidelines. Medicine (Baltimore) 2017;96:e6424. [PMID: 28328848 DOI: 10.1097/MD.0000000000006424] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 24 |
Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, Pearson SA, Leggett B, Whitehall V. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut 2017;66:97-106. [PMID: 26475632 DOI: 10.1136/gutjnl-2015-310456] [Cited by in Crossref: 129] [Cited by in F6Publishing: 135] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 25 |
Bahrami A, Lee S, Schaefer IM, Boland JM, Patton KT, Pounds S, Fletcher CD. TERT promoter mutations and prognosis in solitary fibrous tumor. Mod Pathol 2016;29:1511-22. [PMID: 27562490 DOI: 10.1038/modpathol.2016.126] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 26 |
Robbins P. p53 and Breast Cancer. Int J Surg Pathol 1996;4:93-110. [DOI: 10.1177/106689699600400206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 27 |
Rosa JC, Fonseca I, Félix A, Soares J. p53 Immunoexpression in Carcinomas Arising in Pleomorphic Adenoma. Int J Surg Pathol 1996;3:257-62. [DOI: 10.1177/106689699604030405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 28 |
Gupta S, Khan H, Kushwaha VS, Husain N, Negi M, Ghatak A, Bhatt M. Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiation. Cancer Biol Ther 2015;16:1269-80. [PMID: 26177827 DOI: 10.1080/15384047.2015.1070985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Imazawa T, Nishikawa A, Toyoda K, Furukawa F, Mitsui M, Hirose M. Sequential Alteration of Apoptosis, p53 Expression, and Cell Proliferation in the Rat Pancreas Treated with 4-Hydroxyaminoquinoline 1-Oxide. Toxicol Pathol 2003;31:625-31. [DOI: 10.1080/01926230390241855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 30 |
Wang L, Yu X, Li J, Zhang Z, Hou J, Li F. Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis. BMC Cancer 2016;16:373. [PMID: 27370310 DOI: 10.1186/s12885-016-2427-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 31 |
Wang L, Li J, Hou J, Li M, Cui X, Li S, Yu X, Zhang Z, Liang W, Jiang J, Pang L, Chen Y, Zhao J, Li F. p53 expression but not p16(INK4A) correlates with human papillomavirus-associated esophageal squamous cell carcinoma in Kazakh population. Infect Agent Cancer 2016;11:19. [PMID: 27076841 DOI: 10.1186/s13027-016-0065-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 32 |
Guo J, Xie K, Zheng S. Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer. Int J Biol Sci 2016;12:292-301. [PMID: 26929736 DOI: 10.7150/ijbs.14995] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 33 |
Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, Pearson SA, Klein K, Leggett B, Whitehall V. Serrated tubulovillous adenoma of the large intestine. Histopathology. 2016;68:578-587. [PMID: 26212352 DOI: 10.1111/his.12788] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 34 |
García-García C, Rivas MA, Ibrahim YH, Calvo MT, Gris-Oliver A, Rodríguez O, Grueso J, Antón P, Guzmán M, Aura C, Nuciforo P, Jessen K, Argilés G, Dienstmann R, Bertotti A, Trusolino L, Matito J, Vivancos A, Chicote I, Palmer HG, Tabernero J, Scaltriti M, Baselga J, Serra V. MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer. Clin Cancer Res 2015;21:5499-510. [PMID: 26272063 DOI: 10.1158/1078-0432.CCR-14-3091] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 35 |
Ikeda S, Hansel DE, Kurzrock R. Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma. Cancer Treat Rev 2015;41:699-706. [PMID: 26138514 DOI: 10.1016/j.ctrv.2015.06.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 36 |
Medina-Arana V, Martínez-Riera A, Delgado-Plasencia L, Rodríguez-González D, Bravo-Gutiérrez A, Álvarez-Argüelles H, Alarcó-Hernández A, Salido-Ruiz E, Fernández-Peralta AM, González-Aguilera JJ. Clinicopathological analysis of factors related to colorectal tumor perforation: influence of angiogenesis. Medicine (Baltimore) 2015;94:e703. [PMID: 25881846 DOI: 10.1097/MD.0000000000000703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 37 |
Bettington ML, Walker NI, Rosty C, Brown IS, Clouston AD, McKeone DM, Pearson SA, Klein K, Leggett BA, Whitehall VL. A clinicopathological and molecular analysis of 200 traditional serrated adenomas. Mod Pathol 2015;28:414-27. [PMID: 25216220 DOI: 10.1038/modpathol.2014.122] [Cited by in Crossref: 120] [Cited by in F6Publishing: 123] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 38 |
Shi S, Ji S, Qin Y, Xu J, Zhang B, Xu W, Liu J, Long J, Liu C, Liu L. Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer. Cancer Lett. 2015;360:227-233. [PMID: 25687883 DOI: 10.1016/j.canlet.2015.02.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 39 |
Gupta S, Hansel DE. Molecular Biology of Urothelial Cancer. Urological Oncology 2015. [DOI: 10.1007/978-0-85729-482-1_33] [Reference Citation Analysis]
|
| 40 |
Khan H, Gupta S, Husain N, Misra S, Mps N, Jamal N, Ghatak A. Correlation between expressions of Cyclin-D1, EGFR and p53 with chemoradiation response in patients of locally advanced oral squamous cell carcinoma. BBA Clin 2015;3:11-7. [PMID: 26675419 DOI: 10.1016/j.bbacli.2014.11.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Ando K, Oki E, Saeki H, Yan Z, Tsuda Y, Hidaka G, Kasagi Y, Otsu H, Kawano H, Kitao H, Morita M, Maehara Y. Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer. Cancer Med. 2015;4:75-83. [PMID: 25354498 DOI: 10.1002/cam4.346] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 42 |
Wei K, Jiang L, Wei Y, Wang Y, Qian X, Dai Q, Guan Q. The prognostic significance of p53 expression in gastric cancer: a meta-analysis. J Cancer Res Clin Oncol 2015;141:735-48. [DOI: 10.1007/s00432-014-1844-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 43 |
Sajeevan TP, Saraswathi TR, Ranganathan K, Joshua E, Rao UD. Immunohistochemical study of p53 and proliferating cell nuclear antigen expression in odontogenic keratocyst and periapical cyst. J Pharm Bioallied Sci. 2014;6:S52-S57. [PMID: 25210385 DOI: 10.4103/0975-7406.137388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 44 |
Arjonen A, Kaukonen R, Mattila E, Rouhi P, Högnäs G, Sihto H, Miller BW, Morton JP, Bucher E, Taimen P, Virtakoivu R, Cao Y, Sansom OJ, Joensuu H, Ivaska J. Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis. J Clin Invest 2014;124:1069-82. [PMID: 24487586 DOI: 10.1172/JCI67280] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 45 |
Demir L, Ekinci N, Erten C, Somali I, Can A, Dirican A, Cokmert S, Bayoglu V, Akyol M, Kucukzeybek Y, Alacacioglu A, Tarhan MO. The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer: Cell-Cycle Markers and Colon Cancer Prognosis. J Surg Oncol 2014;109:665-75. [DOI: 10.1002/jso.23563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 46 |
Bellizzi AM. Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms. Seminars in Diagnostic Pathology 2013;30:329-61. [DOI: 10.1053/j.semdp.2013.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 47 |
Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, Yachida S. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. Ann Surg. 2013;258:336-346. [PMID: 23470568 DOI: 10.1097/sla.0b013e3182827a65] [Cited by in Crossref: 158] [Cited by in F6Publishing: 176] [Article Influence: 15.8] [Reference Citation Analysis]
|
| 48 |
Bellizzi AM. Immunohistochemistry in Gastroenterohepatopancreatobiliary Epithelial Neoplasia. Surgical Pathology Clinics 2013;6:567-609. [DOI: 10.1016/j.path.2013.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 49 |
Reimers MS, Zeestraten EC, Kuppen PJ, Liefers GJ, van de Velde CJ. Biomarkers in precision therapy in colorectal cancer. Gastroenterol Rep (Oxf) 2013;1:166-83. [PMID: 24759962 DOI: 10.1093/gastro/got022] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 50 |
Carson NE, Gu J, Ianuzzo CD. Detection of Myosin Heavy Chain in Skeletal Muscles Using Monoclonal Antibodies on Formalin Fixed, Paraffin Embedded Tissue Sections. Journal of Histotechnology 2013;21:19-24. [DOI: 10.1179/his.1998.21.1.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 51 |
Zeestraten EC, Benard A, Reimers MS, Schouten PC, Liefers GJ, van de Velde CJ, Kuppen PJ. The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry. Biomark Cancer 2013;5:13-29. [PMID: 24179395 DOI: 10.4137/BIC.S11475] [Cited by in Crossref: 46] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 52 |
Bertheau P, Fléjou J, Allory Y, Varlet P, Lantuejoul S, Plassa L, de Thé H, Janin A, Lehmann-che J. p53 in the Clinic: A Pathologist’s View. p53 in the Clinics 2013. [DOI: 10.1007/978-1-4614-3676-8_17] [Reference Citation Analysis]
|
| 53 |
Molin MD, Maitra A. Genomic Alterations in Sporadic Pancreatic Cancer. Molecular Genetics of Pancreatic Cancer 2013. [DOI: 10.1007/978-1-4614-6549-2_1] [Reference Citation Analysis]
|
| 54 |
Moore J, Friedman MI, Gansler T, Gramlich TL, Derose PB, Hunt D, Cohen C. Prognostic indicators in male breast carcinoma. Breast J 1998;4:261-9. [PMID: 21223446 DOI: 10.1046/j.1524-4741.1998.440261.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 55 |
Zacchetti A, van Garderen E, Rutteman GR. Immunohistochemical evaluation of p53 expression with different antibodies in malignant canine tumours with or without p53 gene mutation. Vet Comp Oncol 2007;5:108-18. [PMID: 19754794 DOI: 10.1111/j.1476-5829.2006.00120.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 56 |
Fu B, Yachida S, Morgan R, Zhong Y, Montgomery EA, Iacobuzio-Donahue CA. Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol 2012;138:356-66. [PMID: 22912351 DOI: 10.1309/AJCPVT7LC4CRPZSK] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 57 |
Saegusa M, Hashimura M, Suzuki E, Yoshida T, Kuwata T. Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway. Am J Pathol 2012;181:684-92. [PMID: 22698986 DOI: 10.1016/j.ajpath.2012.05.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 58 |
Takano S, Kato Y, Yamamoto T, Kaneko MK, Ishikawa E, Tsujimoto Y, Matsuda M, Nakai K, Yanagiya R, Morita S, Tsuboi K, Matsumura A. Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors. J Neurooncol 2012;108:361-73. [PMID: 22396072 DOI: 10.1007/s11060-012-0837-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 59 |
Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, de Wilde RF, Maitra A, Hicks J, Demarzo AM, Shi C, Sharma R, Laheru D, Edil BH, Wolfgang CL, Schulick RD, Hruban RH, Tang LH, Klimstra DS, Iacobuzio-Donahue CA. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2012;36:173-184. [PMID: 22251937 DOI: 10.1097/pas.0b013e3182417d36] [Cited by in Crossref: 370] [Cited by in F6Publishing: 391] [Article Influence: 33.6] [Reference Citation Analysis]
|
| 60 |
Belt EJ, Brosens RP, Delis-van Diemen PM, Bril H, Tijssen M, van Essen DF, Heymans MW, Beliën JA, Stockmann HB, Meijer S, Meijer GA. Cell cycle proteins predict recurrence in stage II and III colon cancer. Ann Surg Oncol 2012;19 Suppl 3:S682-92. [PMID: 22311118 DOI: 10.1245/s10434-012-2216-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 61 |
Nyiraneza C, Jouret-mourin A, Kartheuser A, Camby P, Plomteux O, Detry R, Dahan K, Sempoux C. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer. Human Pathology 2011;42:1897-910. [DOI: 10.1016/j.humpath.2010.06.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 62 |
Moon A, Won KY, Lee JY, Kang I, Lee S, Lee J. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix. Pathology 2011;43:453-8. [DOI: 10.1097/pat.0b013e3283484a3a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 63 |
Xiao HD, Yamaguchi H, Dias-Santagata D, Kuboki Y, Akhavanfard S, Hatori T, Yamamoto M, Shiratori K, Kobayashi M, Shimizu M, Fernandez-Del Castillo C, Mino-Kenudson M, Furukawa T. Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms. J Pathol 2011;224:508-16. [PMID: 21547907 DOI: 10.1002/path.2875] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 64 |
Oikonomakis I. Colorectal cancer: The issue of uniformity throughout the colon in light of molecular marker expression. Hellenic J Surg 2011;83:57-66. [DOI: 10.1007/s13126-011-0011-8] [Reference Citation Analysis]
|
| 65 |
Matthaei H, Maitra A. Precursor Lesions of Pancreatic Cancer. Pre-Invasive Disease: Pathogenesis and Clinical Management 2011. [DOI: 10.1007/978-1-4419-6694-0_19] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 66 |
Baumgart M, Werther M, Bockholt A, Scheurer M, Rüschoff J, Dietmaier W, Ghadimi BM, Heinmöller E. Genomic instability at both the base pair level and the chromosomal level is detectable in earliest PanIN lesions in tissues of chronic pancreatitis. Pancreas 2010;39:1093-103. [PMID: 20531246 DOI: 10.1097/MPA.0b013e3181dc62f6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 67 |
Shamji MF, Purgina B, Flood T, Michaud J, Ventureyra EC. Pediatric malignant peripheral nerve sheath tumour of the radial nerve. Can J Neurol Sci 2010;37:524-7. [PMID: 20724265 DOI: 10.1017/s0317167100010593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 68 |
Langeveld D, van Hattem WA, de Leng WW, Morsink FH, Ten Kate FJ, Giardiello FM, Offerhaus GJ, Brosens LA. SMAD4 immunohistochemistry reflects genetic status in juvenile polyposis syndrome. Clin Cancer Res. 2010;16:4126-4134. [PMID: 20682711 DOI: 10.1158/1078-0432.ccr-10-0168] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 69 |
Ali S, Awan M, Ghaffar S, Azam S, Pervez S. TP53 protein overexpression in oral squamous cell carcinomas (OSCC): correlation with histologic variables and survival outcome in Pakistani patients. Oral Surgery 2010;3:83-95. [DOI: 10.1111/j.1752-248x.2010.01089.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 70 |
Scott N, Martin I, Jack AS, Dixon MF, Quirke P. Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia. Clin Mol Pathol 1996;49:M151-8. [PMID: 16696064 DOI: 10.1136/mp.49.3.m151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 71 |
Bertorelle R, Esposito G, Belluco C, Bonaldi L, Del Mistro A, Nitti D, Lise M, Chieco-Bianchi L. p53 gene alterations and protein accumulation in colorectal cancer. Clin Mol Pathol 1996;49:M85-90. [PMID: 16696056 DOI: 10.1136/mp.49.2.m85] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 72 |
Ofner D, Maier H, Riedmann B, Holzberger P, Nogler M, Tötsch M, Bankfalvi A, Winde G, Böcker W, Schmid KW. Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance. Clin Mol Pathol 1995;48:M12-6. [PMID: 16695968 DOI: 10.1136/mp.48.1.m12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 73 |
Mavanur AA, Parimi V, O'Malley M, Nikiforova M, Bartlett DL, Davison JM. Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma. Int J Exp Pathol 2010;91:357-67. [PMID: 20586814 DOI: 10.1111/j.1365-2613.2010.00721.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 74 |
Zaanan A, Cuilliere-dartigues P, Guilloux A, Parc Y, Louvet C, de Gramont A, Tiret E, Dumont S, Gayet B, Validire P, Fléjou J, Duval A, Praz F. Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin. Annals of Oncology 2010;21:772-80. [DOI: 10.1093/annonc/mdp383] [Cited by in Crossref: 96] [Cited by in F6Publishing: 102] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 75 |
Kawakami M, Yamaguchi T, Takahashi K, Matsumoto H, Yasutome M, Horiguchi S, Hayashi Y, Funata N, Mori T. Assessment of SMAD4, p53, and Ki-67 alterations as a predictor of liver metastasis in human colorectal cancer. Surg Today 2010;40:245-50. [PMID: 20180078 DOI: 10.1007/s00595-009-4028-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 76 |
Feldmann G, Maitra A. Molecular Pathology of Precursor Lesions of Pancreatic Cancer. Pancreatic Cancer. New York: Springer; 2010. pp. 119-41. [DOI: 10.1007/978-0-387-77498-5_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 77 |
Van Guelpen B, Dahlin AM, Hultdin J, Eklöf V, Johansson I, Henriksson ML, Cullman I, Hallmans G, Palmqvist R. One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study. Cancer Causes Control 2010;21:557-66. [PMID: 20012180 DOI: 10.1007/s10552-009-9484-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 78 |
Koorstra JB, Hong SM, Shi C, Meeker AK, Ryu JK, Offerhaus GJ, Goggins MG, Hruban RH, Maitra A. Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia. Mod Pathol 2009;22:1439-45. [PMID: 19668150 DOI: 10.1038/modpathol.2009.114] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 79 |
Villanacci V, Cestari R, Giulini S, Cengia P, Missale G, Berenzi A, Rossi E, Bonardi M, Baiocchi L, Bassotti G. Immunocytochemical assessment of p53 protein to detect malignancy in increased cell-yield brush cytology from the biliopancreatic tree. Dig Dis Sci 2009;54:789-92. [PMID: 18688713 DOI: 10.1007/s10620-008-0431-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 80 |
Karim S, Ali A. Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India. World J Gastroenterol 2009; 15(11): 1381-1387 [PMID: 19294769 DOI: 10.3748/wjg.15.1381] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 81 |
Tee YT, Wang PH, Yang SF, Ng SC, Ko JL, Chen GD, Chang H, Lin LY. Lymph node metastases, not human telomerase reverse transcriptase or p53 proteins, as the strongest prognostic factor for survival in early stage cervical cancer. J Obstet Gynaecol Res 2008;34:1002-9. [PMID: 19012699 DOI: 10.1111/j.1447-0756.2008.00861.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 82 |
Inagaki Y, Tang W, Xu HL, Guo Q, Mafune K, Konishi T, Nakata M, Sugawara Y, Kokudo N. Localization of N-myc downstream-regulated gene 1 in gastric cancer tissue. Dig Liver Dis 2009;41:96-103. [PMID: 18602353 DOI: 10.1016/j.dld.2008.04.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 83 |
Meng G, Zhang H, Bu H, Geng J. Low-grade fibromyxoid sarcoma versus fibromatosis: A comparative study of clinicopathological and immunohistochemical features. Diagn Cytopathol 2009;37:96-102. [DOI: 10.1002/dc.20967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 84 |
Ogino S, Kirkner GJ, Nosho K, Irahara N, Kure S, Shima K, Hazra A, Chan AT, Dehari R, Giovannucci EL. Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer. Clin Cancer Res. 2008;14:8221-8227. [PMID: 19088039 DOI: 10.1158/1078-0432.ccr-08-1841] [Cited by in Crossref: 152] [Cited by in F6Publishing: 160] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 85 |
Lopes CV, Mnif H, Pesenti C, Bories E, Monges G, Giovannini M. p53 and Ki-67 in Barrett's carcinoma: is there any value to predict recurrence after circumferential endoscopic mucosal resection? Arq Gastroenterol 2007;44:304-8. [PMID: 18317648 DOI: 10.1590/s0004-28032007000400005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 86 |
Saegusa M, Hashimura M, Kuwata T, Hamano M, Watanabe J, Kawaguchi M, Okayasu I. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells. J Pathol 2008;216:521-32. [PMID: 18798221 DOI: 10.1002/path.2404] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 87 |
Alvarez H, Koorstra JB, Hong SM, Boonstra JJ, Dinjens WN, Foratiere AA, Wu TT, Montgomery E, Eshleman JR, Maitra A. Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line. Cancer Biol Ther 2008;7:1753-5. [PMID: 18787394 DOI: 10.4161/cbt.7.11.6723] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 88 |
Genetzakis M, Gomatos IP, Georgiou AN, Giotakis J, Manolopoulos L, Papadimitriou Κ, Chra H, Leandros E, Tsigris C, Ferekidis EA. BCL-2, p53 and HLA-DR antigen expression in surgically treated parotid cancer patients. Eur Arch Otorhinolaryngol 2009;266:417-24. [DOI: 10.1007/s00405-008-0754-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 89 |
Bozikas A, Marsman WA, Rosmolen WD, van Baal JW, Kulik W, ten Kate FJ, Krishnadath KK, Bergman JJ. The effect of oral administration of ursodeoxycholic acid and high-dose proton pump inhibitors on the histology of Barrett's esophagus. Dis Esophagus 2008;21:346-54. [PMID: 18477258 DOI: 10.1111/j.1442-2050.2007.00782.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 90 |
van Eeden S, Offerhaus GJ, Hart AA, Boerrigter L, Nederlof PM, Porter E, van Velthuysen ML. Goblet cell carcinoid of the appendix: a specific type of carcinoma. Histopathology. 2007;51:763-773. [PMID: 18042066 DOI: 10.1111/j.1365-2559.2007.02883.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 74] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 91 |
Muret J, Yacoub M, Terrier P, Drusch F, Laplanche A, Gaudin C, Richon C, Le Péchoux C, Le Cesne A, Lejeune FJ, Tursz T, Fouret P, Bonvalot S, Chouaib S. p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-alpha and melphalan. Ann Oncol 2008;19:793-800. [PMID: 18065405 DOI: 10.1093/annonc/mdm559] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 92 |
Ogino S, Kawasaki T, Kirkner GJ, Ogawa A, Dorfman I, Loda M, Fuchs CS. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. J Pathol. 2006;210:147-154. [PMID: 16850502 DOI: 10.1002/path.2030] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 93 |
Milsmann C, Füzesi L, Heinmöller E, Krause P, Werner C, Becker H, Horstmann O. Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors. Langenbecks Arch Surg 2007;393:49-58. [DOI: 10.1007/s00423-007-0218-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 94 |
Keller S, Schade B, Rickenbacher A, Brugnera E, Wergin M, Müller E, Suter M, Guscetti F. A Comprehensive Test System to Identify Suitable Antibodies Against p53 for Immunohistochemical Analysis of Canine Tissues. Journal of Comparative Pathology 2007;137:59-70. [DOI: 10.1016/j.jcpa.2007.04.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 95 |
Feldmann G, Beaty R, Hruban RH, Maitra A. Molecular genetics of pancreatic intraepithelial neoplasia. J Hepatobiliary Pancreat Surg. 2007;14:224-232. [PMID: 17520196 DOI: 10.1007/s00534-006-1166-5] [Cited by in Crossref: 174] [Cited by in F6Publishing: 193] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 96 |
Coull DB, Lee FD, Anderson JH, McKee RF, Finlay IG, Dunlop MG. Long-term cancer risk of the anorectal cuff following restorative proctocolectomy assessed by p53 expression and cuff dysplasia. Colorectal Dis 2007;9:321-7. [PMID: 17432983 DOI: 10.1111/j.1463-1318.2006.01118.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 97 |
Offerhaus G. Grading gastrointestinal dysplasia and what to call it when you don't know what it is. J Pathol 2007;212:121-3. [DOI: 10.1002/path.2171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 98 |
Kamoshida S, Suzuki M, Shimomura R, Sakurai Y, Komori Y, Uyama I, Tsutsumi Y. Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer. Br J Cancer 2007;96:277-83. [PMID: 17211470 DOI: 10.1038/sj.bjc.6603546] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 99 |
Ogino S, Kawasaki T, Kirkner GJ, Yamaji T, Loda M, Fuchs CS. Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Mod Pathol 2007;20:15-22. [PMID: 17086168 DOI: 10.1038/modpathol.3800709] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 100 |
Einspahr JG, Martinez ME, Jiang R, Hsu CH, Rashid A, Bhattacharrya AK, Ahnen DJ, Jacobs ET, Houlihan PS, Webb CR. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev. 2006;15:1443-1450. [PMID: 16896030 DOI: 10.1158/1055-9965.epi-06-0144] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 101 |
Ogawa T, Yoshida T, Tsuruta T, Saigenji K, Okayasu I. Genetic instability on chromosome 17 in the epithelium of non-polypoid colorectal carcinomas compared to polypoid lesions. Cancer Science 2006;97:1335-42. [DOI: 10.1111/j.1349-7006.2006.00334.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 102 |
Nandi S, Yu J, Burger AM, Reinert LS, Gartenhaus RB. Expression of DNA mismatch repair proteins in transformed non-Hodgkin's lymphoma: relationship to smoking. Leuk Lymphoma 2006;47:1806-12. [PMID: 17064992 DOI: 10.1080/10428190600652137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 103 |
Ahmed FE. Gene-gene, gene-environment & multiple interactions in colorectal cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006;24:1-101. [PMID: 16690537 DOI: 10.1080/10590500600614295] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 104 |
Neal C, Garcea G, Doucas H, Manson M, Sutton C, Dennison A, Berry D. Molecular prognostic markers in resectable colorectal liver metastases: A systematic review. European Journal of Cancer 2006;42:1728-43. [DOI: 10.1016/j.ejca.2006.01.056] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 105 |
Gryfe R. Clinical Implications of Our Advancing Knowledge of Colorectal Cancer Genetics: Inherited Syndromes, Prognosis, Prevention, Screening and Therapeutics. Surgical Clinics of North America 2006;86:787-817. [DOI: 10.1016/j.suc.2006.05.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 106 |
Tokairin Y, Kakinuma S, Arai M, Nishimura M, Okamoto M, Ito E, Akashi M, Miki Y, Kawano T, Iwai T, Shimada Y. Accelerated growth of intestinal tumours after radiation exposure in Mlh1-knockout mice: evaluation of the late effect of radiation on a mouse model of HNPCC. Int J Exp Pathol 2006;87:89-99. [PMID: 16623753 DOI: 10.1111/j.0959-9673.2006.00464.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 107 |
Howe JR. Molecular Markers as a Tool for the Early Diagnosis of Pancreatic Cancer. M. D. Anderson Solid Tumor Oncology Series. [DOI: 10.1007/0-387-21600-6_3] [Reference Citation Analysis]
|
| 108 |
Bedrosian I, Giacco G, Pederson L, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane CH, Janjan N, Skibber JM. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 2006;49:175-82. [PMID: 16392024 DOI: 10.1007/s10350-005-0276-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 109 |
Wistuba II, Virman AK, Gazdar AE. Paired Breast Cancer Cell Lines. Human Cell Culture. [DOI: 10.1007/0-306-46861-1_5] [Reference Citation Analysis]
|
| 110 |
Hilska M, Collan YU, O Laine VJ, Kössi J, Hirsimäki P, Laato M, Roberts PJ. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer. Dis Colon Rectum 2005;48:2197-208. [PMID: 16400510 DOI: 10.1007/s10350-005-0202-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 111 |
Lopes CV, Pereira-lima JC, Hartmann AA, Tonelotto E, Salgado K. O critério de positividade para a análise imunoistoquímica da p53 na confirmação da displasia do esôfago de Barrett faz diferença? Arq Gastroenterol 2005;42:233-7. [DOI: 10.1590/s0004-28032005000400008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 112 |
Lopez-Crapez E, Bibeau F, Thézenas S, Ychou M, Simony-Lafontaine J, Thirion A, Azria D, Grenier J, Senesse P. p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. Br J Cancer. 2005;92:2114-2121. [PMID: 15956964 DOI: 10.1038/sj.bjc.6602622] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 113 |
Steele RJ, Lane DP. P53 in cancer: a paradigm for modern management of cancer. Surgeon 2005;3:197-205. [PMID: 16076005 DOI: 10.1016/s1479-666x(05)80041-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 114 |
Lustosa SA, Logullo A, Artigiani R, Saad SS, Goldenberg A, Matos D. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma. Acta Cir Bras. 2005;20:353-357. [PMID: 16186958 DOI: 10.1590/S0102-86502005000500003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 115 |
Feakins RM. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome. Histopathology 2005;46:270-9. [PMID: 15720412 DOI: 10.1111/j.1365-2559.2005.02071.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 116 |
Steensma DP, List AF. Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity. Mayo Clin Proc 2005;80:681-98. [PMID: 15887439 DOI: 10.4065/80.5.681] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 117 |
Curtin K, Slattery ML, Holubkov R, Edwards S, Holden JA, Samowitz WS. p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry. Appl Immunohistochem Mol Morphol 2004;12:380-6. [PMID: 15536342 DOI: 10.1097/00129039-200412000-00017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 118 |
Erill N, Colomer A, Verdú M, Román R, Condom E, Hannaoui N, Banús JM, Cordon-Cardo C, Puig X. Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression. Diagn Mol Pathol 2004;13:217-23. [PMID: 15538112 DOI: 10.1097/01.pdm.0000137098.03878.00] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 119 |
Yom SS, Rashid A, Rosenthal DI, Elliott DD, Hanna EY, Weber RS, El-Naggar AK. Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance. Mod Pathol 2005;18:315-9. [PMID: 15492756 DOI: 10.1038/modpathol.3800315] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 120 |
Stratigos A, Kapranos N, Petrakou E, Anastasiadou A, Pagouni A, Christofidou E, Petridis A, Papadopoulos O, Kokka E, Antoniou C, Georgala S, Katsambas A. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation. J Eur Acad Dermatol Venerol 2005;19:180-6. [DOI: 10.1111/j.1468-3083.2005.01094.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 121 |
Verelst SJ, Hans J, Hanselmann RG, Wirbel RJ. Genetic instability in primary leiomyosarcoma of bone. Hum Pathol 2004;35:1404-12. [PMID: 15668899 DOI: 10.1016/j.humpath.2004.06.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 122 |
Huang H, Illei PB, Zhao Z, Mazumdar M, Huvos AG, Healey JH, Wexler LH, Gorlick R, Meyers P, Ladanyi M. Ewing Sarcomas With p53 Mutation or p16/p14ARF Homozygous Deletion: A Highly Lethal Subset Associated With Poor Chemoresponse. JCO 2005;23:548-58. [DOI: 10.1200/jco.2005.02.081] [Cited by in Crossref: 196] [Cited by in F6Publishing: 206] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 123 |
Yoshida T, Matsumoto N, Mikami T, Okayasu I. Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours. Br J Cancer 2004;91:1081-8. [PMID: 15292938 DOI: 10.1038/sj.bjc.6602050] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 124 |
Chen W, Cooper TK, Zahnow CA, Overholtzer M, Zhao Z, Ladanyi M, Karp JE, Gokgoz N, Wunder JS, Andrulis IL, Levine AJ, Mankowski JL, Baylin SB. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell 2004;6:387-98. [PMID: 15488761 DOI: 10.1016/j.ccr.2004.08.030] [Cited by in Crossref: 122] [Cited by in F6Publishing: 125] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 125 |
Glasgow SC, Mutch MG. Predictive and Prognostic Genetic Markers in Colorectal Cancer. Seminars in Colon and Rectal Surgery 2004;15:163-170. [DOI: 10.1053/j.scrs.2005.02.002] [Reference Citation Analysis]
|
| 126 |
Skírnisdóttir I, Seidal T, Sorbe B. A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging. Int J Gynecol Cancer 2004;14:259-70. [PMID: 15086725 DOI: 10.1111/j.1048-891X.2004.014209.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 127 |
Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Am J Pathol. 2004;164:1739-1749. [PMID: 15111320 DOI: 10.1016/S0002-9440(10)63732-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 128 |
Rocha FTR, Lourenço LG, Jucá MJ, Leal AT, Paz AMDCD. Expressão da proteína P53 no adenocarcinoma gástrico: correlação clínica, anatomopatológica e significância prognostica. Rev Col Bras Cir 2004;31:186-93. [DOI: 10.1590/s0100-69912004000300008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 129 |
Linderholm B, Lindahl T, Öhd J, Bergh J. Cellular and Tissue Markers in Solid Tumors. Principles of Molecular Oncology 2004. [DOI: 10.1007/978-1-59259-664-5_5] [Reference Citation Analysis]
|
| 130 |
Klump B, Nehls O, Okech T, Hsieh CJ, Gaco V, Gittinger FS, Sarbia M, Borchard F, Greschniok A, Gruenagel HH, Porschen R, Gregor M. Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature. Int J Colorectal Dis 2004;19:23-42. [PMID: 12827409 DOI: 10.1007/s00384-003-0499-7] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 131 |
Lee HK, Lee HS, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP. Prognostic significance of Bcl-2 and p53 expression in gastric cancer. Int J Colorectal Dis 2003;18:518-25. [PMID: 12811476 DOI: 10.1007/s00384-003-0491-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 132 |
Abraham SC, Lee JH, Hruban RH, Argani P, Furth EE, Wu TT. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol. 2003;34:902-910. [PMID: 14562286 DOI: 10.1016/s0046-8177(03)00337-x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 133 |
Heinmöller E, Bockholt A, Werther M, Ziemer M, Müller A, Ghadimi BM, Rüschoff J. Laser microdissection of small tissue samples--application to chronic pancreatitis tissues. Pathol Res Pract 2003;199:363-71. [PMID: 12924436 DOI: 10.1078/0344-0338-00432] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 134 |
van Nederveen FH, Dannenberg H, Sleddens HFBM, de Krijger RR, Dinjens WNM. p53 Alterations and Their Relationship to SDHD Mutations in Parasympathetic Paragangliomas. Mod Pathol 2003;16:849-56. [DOI: 10.1097/01.mp.0000084111.03922.4d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 135 |
Jubb AM, Landon TH, Burwick J, Pham TQ, Frantz GD, Cairns B, Quirke P, Peale FV, Hillan KJ. Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridization. J Pathol 2003;200:577-88. [PMID: 12898593 DOI: 10.1002/path.1371] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 136 |
Pan CC, Chen PC, Wang LS, Lee JY, Chiang H. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours. Histopathology 2003;43:165-72. [PMID: 12877732 DOI: 10.1046/j.1365-2559.2003.01663.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 137 |
Hentschel SJ, McCutcheon lE, Moore W, Durity FA. P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas. Can J Neurol Sci 2003;30:215-9. [PMID: 12945944 DOI: 10.1017/s0317167100002614] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 138 |
Graziano F, Cascinu S. Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? Ann Oncol 2003;14:1026-38. [PMID: 12853343 DOI: 10.1093/annonc/mdg284] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 139 |
Bamias AT, Bai MC, Agnantis NJ, Michael MC, Alamanos YP, Stefanaki SV, Razi ED, Skarlos DV, Kappas AM, Pavlidis NA. Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma. Cancer Invest 2003;21:333-40. [PMID: 12901278 DOI: 10.1081/cnv-120018219] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 140 |
Lashner BA, Bauer WM, Rybicki LA, Goldblum JR. Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis. Am J Gastroenterol 2003;98:1423-7. [PMID: 12818291 DOI: 10.1111/j.1572-0241.2003.07573.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 141 |
Vukovic B, Park PC, Al-Maghrabi J, Beheshti B, Sweet J, Evans A, Trachtenberg J, Squire J. Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma. Oncogene 2003;22:1978-87. [PMID: 12673203 DOI: 10.1038/sj.onc.1206227] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 142 |
Parwani AV, Geradts J, Caspers E, Offerhaus GJ, Yeo CJ, Cameron JL, Klimstra DS, Maitra A, Hruban RH, Argani P. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol 2003;16:299-308. [PMID: 12692194 DOI: 10.1097/01.MP.0000062656.60581.AA] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 143 |
Iacopetta B. TP53 mutation in colorectal cancer. Hum Mutat 2003;21:271-6. [PMID: 12619112 DOI: 10.1002/humu.10175] [Cited by in Crossref: 218] [Cited by in F6Publishing: 231] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 144 |
Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A. TP53 and gastric carcinoma: a review. Hum Mutat 2003;21:258-70. [PMID: 12619111 DOI: 10.1002/humu.10180] [Cited by in Crossref: 172] [Cited by in F6Publishing: 179] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 145 |
Yoshida T, Mikami T, Mitomi H, Okayasu I. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts. J Pathol 2003;199:166-75. [PMID: 12533829 DOI: 10.1002/path.1264] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 146 |
Peyromaure M, Ravery V. Prognostic value of p53 overexpression in bladder tumors treated with Bacillus Calmette-Guerin. Expert Rev Anticancer Ther 2002;2:667-70. [PMID: 12503212 DOI: 10.1586/14737140.2.6.667] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 147 |
Saw RP, Koorey D, Painter D, Gallagher PJ, Solomon MJ. p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer. Br J Surg 2002;89:1409-15. [PMID: 12390383 DOI: 10.1046/j.1365-2168.2002.02222.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 148 |
Hiroshima K, Iyoda A, Shibuya K, Hoshino H, Haga Y, Toyozaki T, Shiba M, Baba M, Fujisawa T, Ohwada H. Evidence of neoangiogenesis and an increase in the number of proliferating cells within the bronchial epithelium of smokers. Cancer 2002;95:1539-45. [PMID: 12237923 DOI: 10.1002/cncr.10850] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 149 |
Erhan Y, Korkut MA, Kara E, Aydede H, Sakarya A, Ilkgü O. Value of p53 protein expression and its relationship with short-term prognosis in colorectal cancer. Ann Saudi Med 2002;22:377-80. [PMID: 17146270 DOI: 10.5144/0256-4947.2002.377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 150 |
Bernard PS, Wittwer CT. Real-Time PCR Technology for Cancer Diagnostics. Clinical Chemistry 2002;48:1178-85. [DOI: 10.1093/clinchem/48.8.1178] [Cited by in Crossref: 178] [Cited by in F6Publishing: 176] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 151 |
Steinert R, Buschmann T, van der Linden M, Fels LM, Lippert H, Reymond MA. The role of proteomics in the diagnosis and outcome prediction in colorectal cancer. Technol Cancer Res Treat 2002;1:297-304. [PMID: 12625789 DOI: 10.1177/153303460200100411] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 152 |
Ansari-Lari MA, Hoque MO, Califano J, Westra WH. Immunohistochemical p53 expression patterns in sarcomatoid carcinomas of the upper respiratory tract. Am J Surg Pathol 2002;26:1024-31. [PMID: 12170089 DOI: 10.1097/00000478-200208000-00007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 153 |
Millward H, Samowitz W, Wittwer CT, Bernard PS. Homogeneous Amplification and Mutation Scanning of the p53 Gene Using Fluorescent Melting Curves. Clinical Chemistry 2002;48:1321-8. [DOI: 10.1093/clinchem/48.8.1321] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 154 |
Kabbani W, Houlihan PS, Luthra R, Hamilton SR, Rashid A. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Mod Pathol 2002;15:599-605. [PMID: 12065772 DOI: 10.1038/modpathol.3880572] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 155 |
Graflund M, Sorbe B, Karlsson M. Immunohistochemical expression of p53, bcl-2, and p21(WAF1/CIP1) in early cervical carcinoma: correlation with clinical outcome. Int J Gynecol Cancer 2002;12:290-8. [PMID: 12060451 DOI: 10.1046/j.1525-1438.2002.01113.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 156 |
van Heek T, Rader AE, Offerhaus GJ, McCarthy DM, Goggins M, Hruban RH, Wilentz RE. K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis. Am J Clin Pathol 2002;117:755-65. [PMID: 12090425 DOI: 10.1309/5RQ0-JCQU-5XF2-51LQ] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 157 |
Abraham SC, Klimstra DS, Wilentz RE, Yeo CJ, Conlon K, Brennan M, Cameron JL, Wu TT, Hruban RH. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 2002;160:1361-9. [PMID: 11943721 DOI: 10.1016/s0002-9440(10)62563-1] [Cited by in Crossref: 363] [Cited by in F6Publishing: 378] [Article Influence: 17.3] [Reference Citation Analysis]
|
| 158 |
Adams SA, Hilton DA. Recurrent haemangioblastoma with glial differentiation. Neuropathol Appl Neurobiol 2002;28:142-6. [PMID: 11972801 DOI: 10.1046/j.1365-2990.2002.00371.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 159 |
Cascinu S, Graziano F, Catalano V, Staccioli MP, Rossi MC, Baldelli AM, Barni S, Brenna A, Secondino S, Muretto P, Catalano G. An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation. Br J Cancer 2002;86:744-9. [PMID: 11875737 DOI: 10.1038/sj.bjc.6600155] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 160 |
Nakajima Y, Nagai K, Miyake S, Ohashi K, Kawano T, Iwai T. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer. Jpn J Cancer Res 2002;93:305-12. [PMID: 11927013 DOI: 10.1111/j.1349-7006.2002.tb02173.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 161 |
Abraham SC, Wu TT, Hruban RH, Lee JH, Yeo CJ, Conlon K, Brennan M, Cameron JL, Klimstra DS. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 2002;160:953-62. [PMID: 11891193 DOI: 10.1016/s0002-9440(10)64917-6] [Cited by in Crossref: 211] [Cited by in F6Publishing: 223] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 162 |
Yanagisawa N, Saegusa M, Yoshida T, Okayasu I. Squamous cell carcinoma arising from a seminal vesicular cyst: possible relationship between chronic inflammation and tumor development. Pathol Int 2002;52:249-53. [PMID: 11972870 DOI: 10.1046/j.1440-1827.2002.01340.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 163 |
Horn LC, Fischer U, Hänel C, Kuhn H, Raptis G, Bilek K. p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread. Pathol Res Pract 2001;197:605-9. [PMID: 11569924 DOI: 10.1078/0344-0338-00134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 164 |
Liang JT, Huang KC, Cheng YM, Hsu HC, Cheng AL, Hsu CH, Yeh KH, Wang SM, Chang KJ. P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection. Int J Cancer 2002;97:451-7. [PMID: 11802206 DOI: 10.1002/ijc.1637] [Cited by in Crossref: 52] [Cited by in F6Publishing: 100] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 165 |
Formenti SC, Spicer D, Skinner K, Cohen D, Groshen S, Bettini A, Naritoku W, Press M, Salonga D, Tsao-Wei D, Danenberg K, Danenberg P. Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer. Int J Radiat Oncol Biol Phys 2002;52:397-405. [PMID: 11872285 DOI: 10.1016/s0360-3016(01)02655-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 166 |
Chang MS, Lee HS, Kim CW, Kim YI, Kim WH. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol Res Pract 2001;197:395-400. [PMID: 11432666 DOI: 10.1078/0344-0338-00052] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 167 |
Liang J, Jeng Y. 2 Role of immunohistochemical expression of p53 in colorectal carcinoma. Molecular Pathology, Colorectal Carcinoma, and Prostate Carcinoma 2002. [DOI: 10.1016/s1874-5784(02)80018-6] [Reference Citation Analysis]
|
| 168 |
Wang HL. 16 Role of immunohistochemical expression of p53, Rb, and p16 proteins in anal squamous cell carcinoma. Molecular Pathology, Colorectal Carcinoma, and Prostate Carcinoma 2002. [DOI: 10.1016/s1874-5784(02)80032-0] [Reference Citation Analysis]
|
| 169 |
Verstegen MJ, Leenstra DT, Ijlst-Keizers H, Bosch DA. Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis. J Neurooncol 2002;56:21-8. [PMID: 11949823 DOI: 10.1023/a:1014471714058] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 170 |
Soliman AS, Bondy ML, El-Badawy SA, Mokhtar N, Eissa S, Bayoumy S, Seifeldin IA, Houlihan PS, Lukish JR, Watanabe T. Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients. Br J Cancer. 2001;85:1037-1046. [PMID: 11592777 DOI: 10.1038/sj.bjc.6691838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 171 |
Ong F, Moonen LM, Gallee MP, ten Bosch C, Zerp SF, Hart AA, Bartelink H, Verheij M. Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53. Radiother Oncol 2001;61:169-75. [PMID: 11690683 DOI: 10.1016/s0167-8140(01)00421-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 172 |
Buglioni S, D'Agnano I, Vasselli S, Perrone Donnorso R, D'Angelo C, Brenna A, Benevolo M, Cosimelli M, Zupi G, Mottolese M. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy. Am J Clin Pathol 2001;116:360-8. [PMID: 11554164 DOI: 10.1309/V7UW-UT2E-JVYH-DGWK] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 173 |
Saegusa M, Machida B D, Okayasu I. Possible associations among expression of p14(ARF), p16(INK4a), p21(WAF1/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas. Cancer 2001;92:1177-89. [PMID: 11571731 DOI: 10.1002/1097-0142(20010901)92:5<1177::aid-cncr1436>3.0.co;2-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 174 |
Soliman AS, Bondy ML, El-Badawy SA, Mokhtar N, Eissa S, Bayoumy S, Seifeldin IA, Houlihan PS, Lukish JR, Watanabe T, Chan AO, Zhu D, Amos CI, Levin B, Hamilton SR. Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients. Br J Cancer 2001;85:1037-46. [PMID: 11592777 DOI: 10.1054/bjoc.2001.1838] [Cited by in Crossref: 50] [Cited by in F6Publishing: 59] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 175 |
O'Connor DP, Kay EW, Leader M, Murphy GM, Atkins GJ, Mabruk MJ. Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: correlation with human papillomaviruses? Diagn Mol Pathol 2001;10:190-9. [PMID: 11552722 DOI: 10.1097/00019606-200109000-00007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 176 |
Leichman CG. Predictive and prognostic markers in gastrointestinal cancers. Curr Opin Oncol 2001;13:291-9. [PMID: 11429488 DOI: 10.1097/00001622-200107000-00013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 177 |
Nasierowska-Guttmejer A, Trzeciak L, Nowacki MP, Ostrowski J. p53 protein accumulation and p53 gene mutation in colorectal cancer. Pathol Oncol Res 2000;6:275-9. [PMID: 11173660 DOI: 10.1007/BF03187331] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 178 |
Wilentz RE, Argani P, Hruban RH. Loss of heterozygosity or intragenic mutation, which comes first? Am J Pathol 2001;158:1561-3. [PMID: 11337351 DOI: 10.1016/S0002-9440(10)64109-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 179 |
Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB 3rd, Hamilton SR. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001;344:1196-206. [PMID: 11309634 DOI: 10.1056/NEJM200104193441603] [Cited by in Crossref: 648] [Cited by in F6Publishing: 693] [Article Influence: 29.5] [Reference Citation Analysis]
|
| 180 |
Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, Lin HA, Robertson MA, Nichols MF, Gruenthal KM, Lynch BJ, Leppert MF, Slattery ML. Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol 2001;158:1517-24. [PMID: 11290569 DOI: 10.1016/S0002-9440(10)64102-8] [Cited by in Crossref: 133] [Cited by in F6Publishing: 145] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 181 |
Shingu K, Kobayashi S, Yokoyama S, Fujimori M, Asanuma K, Ito KI, Hama Y, Maruyama M, Kusama R, Amano J. The likely transformation of papillary thyroid carcinoma into anaplastic carcinoma during postoperative radioactive iodine-131 therapy: report of a case. Surg Today 2000;30:910-3. [PMID: 11059731 DOI: 10.1007/s005950070043] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 182 |
Nambiar PR, Jackson ML, Ellis JA, Chelack BJ, Kidney BA, Haines DM. Immunohistochemical detection of tumor suppressor gene p53 protein in feline injection site-associated sarcomas. Vet Pathol 2001;38:236-8. [PMID: 11280384 DOI: 10.1354/vp.38-2-236] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 183 |
Entius MM, Keller JJ, Westerman AM, van Rees BP, van Velthuysen ML, de Goeij AF, Wilson JH, Giardiello FM, Offerhaus GJ. Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome. J Clin Pathol 2001;54:126-31. [PMID: 11215281 DOI: 10.1136/jcp.54.2.126] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 184 |
Takaku H, Ajioka Y, Watanabe H, Hashidate H, Yamada S, Yokoyama J, Kazama S, Suda T, Hatakeyama K. Mutations of p53 in morphologically non-neoplastic mucosa of long-standing ulcerative colitis. Jpn J Cancer Res 2001;92:119-26. [PMID: 11223540 DOI: 10.1111/j.1349-7006.2001.tb01073.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 185 |
Burri N, Shaw P, Bouzourene H, Sordat I, Sordat B, Gillet M, Schorderet D, Bosman FT, Chaubert P. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest 2001;81:217-29. [PMID: 11232644 DOI: 10.1038/labinvest.3780230] [Cited by in Crossref: 127] [Cited by in F6Publishing: 134] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 186 |
Edström S, Cvetkovska E, Westin T, Young C. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer. Laryngoscope 2001;111:124-30. [PMID: 11192880 DOI: 10.1097/00005537-200101000-00022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 187 |
Argani P, Shaukat A, Kaushal M, Wilentz RE, Su GH, Sohn TA, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Differing rates of loss ofDPC4 expression and ofp53 overexpression among carcinomas of the proximal and distal bile ducts: Evidence for a biologic distinction. Cancer 2001;91:1332-41. [DOI: 10.1002/1097-0142(20010401)91:7<1332::aid-cncr1136>3.0.co;2-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 188 |
Fan CY. Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair. Curr Oncol Rep 2001;3:66-71. [PMID: 11123872 DOI: 10.1007/s11912-001-0045-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 189 |
Curtis LJ, Georgiades IB, White S, Bird CC, Harrison DJ, Wyllie AH. Specific patterns of chromosomal abnormalities are associated with RER status in sporadic colorectal cancer. J Pathol 2000;192:440-5. [PMID: 11113860 DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH761>3.0.CO;2-X] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 190 |
Ho GH, Calvano JE, Bisogna M, Borgen PI, Rosen PP, Tan LK, Van Zee KJ. In microdissected ductal carcinoma in situ, HER-2/neu amplification, but not p53 mutation, is associated with high nuclear grade and comedo histology. Cancer 2000;89:2153-60. [PMID: 11147584 DOI: 10.1002/1097-0142(20001201)89:11<2153::aid-cncr2>3.0.co;2-o] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 191 |
Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000;119:323-32. [PMID: 10930367 DOI: 10.1053/gast.2000.9361] [Cited by in Crossref: 171] [Cited by in F6Publishing: 174] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 192 |
Cascinu S, Catalano V, Aschele C, Barni S, Debernardis D, Gallo L, Bandelloni R, Staccioli MP, Baldelli AM, Brenna A, Valenti A, Muretto P, Catalano G. Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination. Ann Oncol 2000;11:1053-6. [PMID: 11038045 DOI: 10.1023/a:1008362511552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 193 |
Langendijk H, Thunnissen E, Arends JW, de Jong J, ten Velde G, Lamers R, Guinee D, Holden J, Wouters M. Cell proliferation and apoptosis in stage III inoperable non-small cell lung carcinoma treated by radiotherapy. Radiother Oncol 2000;56:197-207. [PMID: 10927139 DOI: 10.1016/s0167-8140(00)00218-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 194 |
Chang K, Sarraj S, Lin S, Tsai P, Solt D. p53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 2000;21:1441-51. [DOI: 10.1093/carcin/21.5.441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 195 |
Chang K, Sarraj S, Lin S, Tsai P, Solt D. p53 expression, p53 and Ha- ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 2000;21:1441-51. [DOI: 10.1093/carcin/21.7.1441] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 196 |
Heinmöller E, Dietmaier W, Zirngibl H, Heinmöller P, Scaringe W, Jauch KW, Hofstädter F, Rüschoff J. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol 2000;157:83-92. [PMID: 10880379 DOI: 10.1016/S0002-9440(10)64520-8] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 197 |
Shen KL, Yang LS, Hsieh HF, Chen CJ, Yu JC, Tsai NM, Harn HJ. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity. J Surg Oncol 2000;74:100-7. [PMID: 10914818 DOI: 10.1002/1096-9098(200006)74:2<100::AID-JSO5>3.0.CO;2-O] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 198 |
Geisler JP, Geisler HE, Miller GA, Wiemann MC, Zhou Z, Crabtree W. p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months. Gynecol Oncol 2000;77:278-82. [PMID: 10785478 DOI: 10.1006/gyno.2000.5780] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 199 |
Kahlenberg MS, Stoler DL, Rodriguez-bigas MA, Weber TK, Driscoll DL, Anderson GR, Petrelli NJ. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma. Cancer 2000;88:1814-9. [DOI: 10.1002/(sici)1097-0142(20000415)88:8<1814::aid-cncr9>3.0.co;2-i] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 200 |
Kudo Y, Takata T, Ogawa I, Zhao M, Sato S, Takekoshi T, Miyauchi M, Nikai H. Reduced expression of p27(Kip1) correlates with an early stage of cancer invasion in oral squamous cell carcinoma. Cancer Lett 2000;151:217-22. [PMID: 10738117 DOI: 10.1016/s0304-3835(99)00419-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 201 |
Rioux-Leclercq N, Turlin B, Bansard J, Patard J, Manunta A, Moulinoux JP, Guillé F, Ramée MP, Lobel B. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma. Urology 2000;55:501-5. [PMID: 10736491 DOI: 10.1016/s0090-4295(99)00550-6] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 202 |
van Sandick JW, Baak JP, van Lanschot JJ, Polkowski W, ten Kate FJ, Obertop H, Offerhaus GJ. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus. J Pathol. 2000;190:177-183. [PMID: 10657016 DOI: 10.1002/(SICI)1096-9896(200002)190:2%3C177::AID-PATH508%3E3.0.CO;2-X] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 203 |
Kaserer K, Schmaus J, Bethge U, Migschitz B, Fasching S, Walch A, Herbst F, Teleky B, Wrba F. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer. J Pathol 2000;190:450-6. [PMID: 10699994 DOI: 10.1002/(SICI)1096-9896(200003)190:4<450::AID-PATH545>3.0.CO;2-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 204 |
Antonescu CR, Leung DH, Dudas M, Ladanyi M, Brennan M, Woodruff JM, Cordon-Cardo C. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications. Am J Pathol 2000;156:977-83. [PMID: 10702413 DOI: 10.1016/S0002-9440(10)64965-6] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 205 |
Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol 2000;24:429-41. [PMID: 10716158 DOI: 10.1097/00000478-200003000-00013] [Cited by in Crossref: 205] [Cited by in F6Publishing: 205] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 206 |
van Sandick JW, Baak JP, van Lanschot JJ, Polkowski W, ten Kate FJ, Obertop H, Offerhaus GJ. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus. J Pathol 2000;190:177-83. [PMID: 10657016 DOI: 10.1002/(SICI)1096-9896(200002)190:2<177::AID-PATH508>3.0.CO;2-X] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 207 |
Saegusa M, Machida D, Okayasu I. Loss of DCC gene expression during ovarian tumorigenesis: relation to tumour differentiation and progression. Br J Cancer 2000;82:571-8. [PMID: 10682668 DOI: 10.1054/bjoc.1999.0966] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 208 |
Kaye PV, Radebold K, Isaacs S, Dent DM. Expression of p53 and p21waf1/cip1 in gastric carcinoma: lack of inter-relationship or correlation with prognosis. Eur J Surg Oncol 2000;26:39-43. [PMID: 10718178 DOI: 10.1053/ejso.1999.0738] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 209 |
Buglioni S, D'Agnano I, Cosimelli M, Vasselli S, D'Angelo C, Tedesco M, Zupi G, Mottolese M. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2. Int J Cancer 1999;84:545-52. [PMID: 10567896 DOI: 10.1002/(sici)1097-0215(19991222)84:6<545::aid-ijc1>3.0.co;2-2] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 210 |
Keller JJ, Offerhaus GJ, Polak M, Goodman SN, Zahurak ML, Hylind LM, Hamilton SR, Giardiello FM. Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Gut 1999;45:822-8. [PMID: 10562579 DOI: 10.1136/gut.45.6.822] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 211 |
Roviello F, Marrelli D, Vindigni C, De Stefano A, Spina D, Pinto E. P53 accumulation is a prognostic factor in intestinal-type gastric carcinoma but not in the diffuse type. Ann Surg Oncol 1999;6:739-45. [PMID: 10622501 DOI: 10.1007/s10434-999-0739-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 212 |
Einspahr JG, Alberts DS, Warneke JA, Bozzo P, Basye J, Grogan TM, Nelson MA, Bowden GT. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis. Neoplasia 1999;1:468-75. [PMID: 10933063 DOI: 10.1038/sj.neo.7900061] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 213 |
Tascilar M, Sturm PD, Caspers E, Smit M, Polak MM, Huibregtse K, Noorduyn LA, Offerhaus GJ. Diagnostic p53 immunostaining of endobiliary brush cytology: preoperative cytology compared with the surgical specimen. Cancer 1999;87:306-11. [PMID: 10536357 DOI: 10.1002/(sici)1097-0142(19991025)87:5<306::aid-cncr11>3.0.co;2-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 214 |
Bernardini S, Adessi G, Billerey C, Chezy E, Carbillet J, Bittard H. IMMUNOHISTOCHEMICAL DETECTION OF p53 PROTEIN OVEREXPRESSION VERSUS GENE SEQUENCING IN URINARY BLADDER CARCINOMAS: . The Journal of Urology. [DOI: 10.1097/00005392-199910000-00091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 215 |
Bernardini S, Adessi G, Billerey C, Chezy E, Carbillet J, Bittard H. IMMUNOHISTOCHEMICAL DETECTION OF p53 PROTEIN OVEREXPRESSION VERSUS GENE SEQUENCING IN URINARY BLADDER CARCINOMAS. Journal of Urology 1999;162:1496-501. [DOI: 10.1016/s0022-5347(05)68347-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 216 |
Jimenez RE, Warshaw AL, Z'graggen K, Hartwig W, Taylor DZ, Compton CC, Fernández-del Castillo C. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann Surg 1999;230:501-9; discussion 509-11. [PMID: 10522720 DOI: 10.1097/00000658-199910000-00006] [Cited by in Crossref: 142] [Cited by in F6Publishing: 152] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 217 |
Fléjou JF, Gratio V, Muzeau F, Hamelin R. p53 abnormalities in adenocarcinoma of the gastric cardia and antrum. Mol Pathol 1999;52:263-8. [PMID: 10748875 DOI: 10.1136/mp.52.5.263] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 218 |
Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple LK, Hsieh E, Hiruki T, Narod S, Bapat BV, Gallinger S, Redston M. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999;23:1248-55. [PMID: 10524526 DOI: 10.1097/00000478-199910000-00010] [Cited by in Crossref: 171] [Cited by in F6Publishing: 179] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 219 |
Taylor D, Koch WM, Zahurak M, Shah K, Sidransky D, Westra WH. Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. Hum Pathol 1999;30:1221-5. [PMID: 10534171 DOI: 10.1016/s0046-8177(99)90041-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 220 |
Hudson AR, Antley CM, Kohler S, Smoller BR. Increased p53 staining in normal skin of posttransplant, immunocompromised patients and implications for carcinogenesis. Am J Dermatopathol 1999;21:442-5. [PMID: 10535572 DOI: 10.1097/00000372-199910000-00006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 221 |
Ong AC, Harris PC, Davies DR, Pritchard L, Rossetti S, Biddolph S, Vaux DJ, Migone N, Ward CJ. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue. Kidney Int 1999;56:1324-33. [PMID: 10504485 DOI: 10.1046/j.1523-1755.1999.00659.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 222 |
Xie X, Clausen OP, De Angelis P, Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 1999;86:913-20. [PMID: 10491515 DOI: 10.1002/(sici)1097-0142(19990915)86:6<913::aid-cncr4>3.0.co;2-a] [Cited by in Crossref: 98] [Cited by in F6Publishing: 103] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 223 |
Burton JL, Stewart RL, Heatley MK, Royds JA, Wells M. p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma. Histopathology 1999;35:221-9. [PMID: 10469214 DOI: 10.1046/j.1365-2559.1999.00703.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 224 |
Wong CS, Tsao MS, Sharma V, Chapman WB, Pintilie M, Cummings BJ. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1999;45:309-14. [PMID: 10487550 DOI: 10.1016/s0360-3016(99)00188-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 225 |
Walsh SV, Loda M, Torres CM, Antonioli D, Odze RD. P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am J Surg Pathol 1999;23:963-9. [PMID: 10435567 DOI: 10.1097/00000478-199908000-00015] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 226 |
Feakins RM, Mulcahy HE, Nickols CD, Wells CA. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome. Histopathology 1999;35:162-9. [PMID: 10460662 DOI: 10.1046/j.1365-2559.1999.00682.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 227 |
Liapis H, Marley EF, Lin Y, Dehner LP. p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children. Pediatr Dev Pathol 1999;2:377-84. [PMID: 10347283 DOI: 10.1007/s100249900138] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 228 |
Saegusa M, Nitta H, Hashimura M, Okayasu I. Down-regulation of p27Kip1 expression is correlated with increased cell proliferation but not expression of p21waf1 and p53, and human papillomavirus infection in benign and malignant tumours of sinonasal regions. Histopathology 1999;35:55-64. [PMID: 10383715 DOI: 10.1046/j.1365-2559.1999.00688.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 229 |
Rashid A, Zahurak M, Goodman SN, Hamilton SR. Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut 1999;44:826-33. [PMID: 10323885 DOI: 10.1136/gut.44.6.826] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 230 |
Shomori K, Sakatani T, Goto A, Matsuura T, Kiyonari H, Ito H. Thymidine phosphorylase expression in human colorectal mucosa, adenoma and carcinoma: role of p53 expression. Pathol Int 1999;49:491-9. [PMID: 10469391 DOI: 10.1046/j.1440-1827.1999.00897.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 231 |
Voskuil DW, Kampman E, van Kraats AA, Balder HF, van Muijen GN, Goldbohm RA, van't Veer P. p53 over-expression and p53 mutations in colon carcinomas: relation to dietary risk factors. Int J Cancer 1999;81:675-81. [PMID: 10328215 DOI: 10.1002/(sici)1097-0215(19990531)81:5<675::aid-ijc1>3.0.co;2-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 232 |
Würl P, Meye A, Lautenschläger C, Schmidt H, Bache M, Kalthoff H, Schönfelder M, Rath FW, Taubert H. Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas. Cancer Lett 1999;139:159-65. [PMID: 10395173 DOI: 10.1016/s0304-3835(99)00034-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 233 |
Tak PP, Smeets TJ, Boyle DL, Kraan MC, Shi Y, Zhuang S, Zvaifler NJ, Breedveld FC, Firestein GS. p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis. Arthritis Rheum 1999;42:948-53. [PMID: 10323450 DOI: 10.1002/1529-0131(199905)42:5<948::AID-ANR13>3.0.CO;2-L] [Cited by in Crossref: 58] [Cited by in F6Publishing: 76] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 234 |
Hayakawa M, Shimokawa K, Kusugami K, Sugihara M, Morooka Y, Fujita T, Nakamura M, Nishio Y, Maeda K, Ando T, Peek RM. Clinicopathological features of superficial depressed-type colorectal neoplastic lesions. Am J Gastroenterol 1999;94:944-9. [PMID: 10201461 DOI: 10.1111/j.1572-0241.1999.991_n.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 235 |
Lashner BA, Shapiro BD, Husain A, Goldblum JR. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am J Gastroenterol 1999;94:456-62. [PMID: 10022646 DOI: 10.1111/j.1572-0241.1999.877_f.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 236 |
Kressner U, Inganäs M, Byding S, Blikstad I, Påhlman L, Glimelius B, Lindmark G. Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol 1999;17:593-9. [PMID: 10080604 DOI: 10.1200/JCO.1999.17.2.593] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 237 |
Inoue M, Shiramizu K. Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumours. J Comp Pathol 1999;120:169-75. [PMID: 10087490 DOI: 10.1053/jcpa.1998.0268] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 238 |
Tatemoto Y, Osaki T, Yoneda K, Yamamoto T, Ueta E, Kimura T. Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy. Pathol Res Pract 1998;194:821-30. [PMID: 9894247 DOI: 10.1016/S0344-0338(98)80084-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 239 |
Mikami T, Yanagisawa N, Baba H, Koike M, Okayasu I. Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis. Cancer 1999;85:318-25. [DOI: 10.1002/(sici)1097-0142(19990115)85:2<318::aid-cncr8>3.0.co;2-s] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 240 |
Blok P, Craanen ME, Dekker W, Offerhaus GJ, Tytgat GN. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. J Pathol. 1998;186:36-40. [PMID: 9875138 DOI: 10.1002/(SICI)1096-9896(199809)186:1%3C36::AID-PATH150%3E3.0.CO;2-R] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 241 |
McLeod HL, Murray GI. Tumour markers of prognosis in colorectal cancer. Br J Cancer 1999;79:191-203. [PMID: 9888457 DOI: 10.1038/sj.bjc.6690033] [Cited by in Crossref: 157] [Cited by in F6Publishing: 168] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 242 |
Manne U, Weiss HL, Myers RB, Danner OK, Moron C, Srivastava S, Grizzle WE. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Cancer 1998;83:2456-67. [PMID: 9874449 DOI: 10.1002/(sici)1097-0142(19981215)83:12<2456::aid-cncr8>3.0.co;2-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 243 |
Sturm PD, Baas IO, Clement MJ, Nakeeb A, Johan G, Offerhaus A, Hruban RH, Pitt HA. Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area. Int J Cancer 1998;78:695-8. [PMID: 9833761 DOI: 10.1002/(sici)1097-0215(19981209)78:6<695::aid-ijc5>3.0.co;2-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 244 |
Sobti RC, Parashar K. A study on p53 protein and anti-p53 antibodies in the sera of patients with oesophageal cancer. Mutat Res 1998;422:271-7. [PMID: 9838161 DOI: 10.1016/s0027-5107(98)00207-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 245 |
Cascinu S, Graziano F, Ferro ED, Staccioli MP, Ligi M, Carnevali A, Muretto P, Catalano G. Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma. Cancer 1998;83:1917-22. [DOI: 10.1002/(sici)1097-0142(19981101)83:9<1917::aid-cncr6>3.0.co;2-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 246 |
Keegan PE, Lunec J, Neal DE. p53 and p53-regulated genes in bladder cancer. Br J Urol 1998;82:710-20. [PMID: 9839588 DOI: 10.1046/j.1464-410x.1998.00822.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 247 |
Sturm PD, Hruban RH, Ramsoekh TB, Noorduyn LA, Tytgat GN, Gouma DJ, Offerhaus GJ. The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol 1998;186:247-53. [PMID: 10211112 DOI: 10.1002/(SICI)1096-9896(1998110)186:3<247::AID-PATH179>3.0.CO;2-J] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 248 |
Sur M, Cooper K. The role of the human papilloma virus in esophageal cancer. Pathology 1998;30:348-54. [PMID: 9839308 DOI: 10.1080/00313029800169616] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 249 |
Steele RJ, Thompson AM, Hall PA, Lane DP. The p53 tumour suppressor gene. Br J Surg 1998;85:1460-7. [PMID: 9823903 DOI: 10.1046/j.1365-2168.1998.00910.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 140] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 250 |
Fujiwara T, Stolker JM, Watanabe T, Rashid A, Longo P, Eshleman JR, Booker S, Lynch HT, Jass JR, Green JS, Kim H, Jen J, Vogelstein B, Hamilton SR. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 1998;153:1063-78. [PMID: 9777938 DOI: 10.1016/S0002-9440(10)65651-9] [Cited by in Crossref: 130] [Cited by in F6Publishing: 145] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 251 |
Athanassiadou P, Dosios T, Petrakakou E, Liossi A, Zerva C, Athanassiades P. p53 and bcl-2 protein expression in non-small-cell lung carcinoma. Diagn Cytopathol 1998;19:255-9. [PMID: 9784987 DOI: 10.1002/(sici)1097-0339(199810)19:4<255::aid-dc5>3.0.co;2-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 252 |
Chiba I, Muthumala M, Yamazaki Y, Uz Zaman A, Iizuka T, Amemiya A, Shibata T, Kashiwazaki H, Sugiura C, Fukuda H. Characteristics of mutations in the p53 gene of oral squamous-cell carcinomas associated with betel-quid chewing in Sri Lanka. Int J Cancer 1998;77:839-42. [PMID: 9714051 DOI: 10.1002/(sici)1097-0215(19980911)77:6<839::aid-ijc7>3.0.co;2-v] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 253 |
Rohan TE, Hartwick W, Miller AB, Kandel RA. Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk. J Natl Cancer Inst 1998;90:1262-9. [PMID: 9731732 DOI: 10.1093/jnci/90.17.1262] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 254 |
Blok P, Craanen ME, Dekker W, Offerhaus GJ, Tytgat GN. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. J Pathol 1998;186:36-40. [PMID: 9875138 DOI: 10.1002/(SICI)1096-9896(199809)186:1<36::AID-PATH150>3.0.CO;2-R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 255 |
Baas IO, van Rees BP, Musler A, Craanen ME, Tytgat GN, van den Berg FM, Offerhaus GJ. Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. J Clin Pathol 1998;51:662-6. [PMID: 9930069 DOI: 10.1136/jcp.51.9.662] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 256 |
Mighell AJ, Hume WJ, Robinson PA. An overview of the complexities and subtleties of immunohistochemistry. Oral Dis 1998;4:217-23. [PMID: 9972174 DOI: 10.1111/j.1601-0825.1998.tb00282.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 257 |
Taubert H, Meye A, Bache M, Hinze R, Holzhausen HJ, Schmidt H, Rath FW, Dunst J, Würl P. p53 status in radiation-induced soft-tissue sarcomas. Strahlenther Onkol 1998;174:427-30. [PMID: 9739384 DOI: 10.1007/BF03038565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 258 |
Slebos RJ, Baas IO, Clement MJ, Offerhaus GJ, Askin FB, Hruban RH, Westra WH. p53 alterations in atypical alveolar hyperplasia of the human lung. Hum Pathol 1998;29:801-8. [PMID: 9712420 DOI: 10.1016/s0046-8177(98)90448-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 259 |
Clausen OP, Lothe RA, Børresen-Dale AL, De Angelis P, Chen Y, Rognum TO, Meling GI. Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas. Diagn Mol Pathol 1998;7:215-23. [PMID: 9917132 DOI: 10.1097/00019606-199808000-00006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 260 |
Lee CS, Chou ST. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin. Pathology 1998;30:272-5. [PMID: 9770192 DOI: 10.1080/00313029800169436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 261 |
Schifter M, Jones AM, Walker DM. Epithelial p53 gene expression and mutational analysis, combined with growth fraction assessment, in oral lichen planus. J Oral Pathol Med 1998;27:318-24. [PMID: 9725569 DOI: 10.1111/j.1600-0714.1998.tb01963.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 262 |
Nakata B, Chung KH, Ogawa M, Ogawa Y, Yanagawa K, Muguruma K, Inoue T, Yamashita Y, Onoda N, Maeda K, Sawada T, Sowa M. p53 protein overexpression as a predictor of the response to chemotherapy in gastric cancer. Surg Today 1998;28:595-8. [PMID: 9681607 DOI: 10.1007/s005950050190] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 263 |
el Sebaï H, Ged C, Bonichon F, de Verneuil H, Longy M. Genetic alterations in colorectal cancer, comparative analysis of deletion events, and point mutations. Cancer Genet Cytogenet 1998;104:32-8. [PMID: 9648555 DOI: 10.1016/s0165-4608(97)00415-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 264 |
Polge A, Bourgaux JF, Bancel E, Pignodel C, Boyer JC, Poirey S, de Bornier BM, Balmes JL, Bali JP. p53 and follow-up of colorectal adenocarcinomas. Dig Dis Sci 1998;43:1434-42. [PMID: 9690377 DOI: 10.1023/a:1018890126260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 265 |
Gisbertz IA, Schouten HC, Bot FJ, Arends JW. Cell turnover parameters in small and large cell varieties of primary intestinal non-Hodgkin's lymphoma. Cancer 1998;83:158-65. [PMID: 9655306 DOI: 10.1002/(sici)1097-0142(19980701)83:1<158::aid-cncr21>3.0.co;2-v] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 266 |
Wu TT, Watanabe T, Heitmiller R, Zahurak M, Forastiere AA, Hamilton SR. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol 1998;153:287-94. [PMID: 9665490 DOI: 10.1016/S0002-9440(10)65570-8] [Cited by in Crossref: 93] [Cited by in F6Publishing: 100] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 267 |
Tollenaar RA, van Krieken JH, van Slooten HJ, Bruinvels DJ, Nelemans KM, van den Broek LJ, Hermans J, van Dierendonck JH. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer 1998;77:1842-7. [PMID: 9667656 DOI: 10.1038/bjc.1998.306] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 268 |
Scott N, Hale A, Deakin M, Hand P, Adab FA, Hall C, Williams GT, Elder JB. A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression. Eur J Surg Oncol 1998;24:169-73. [PMID: 9630854 DOI: 10.1016/s0748-7983(98)92861-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 269 |
Kaklamanis L, Savage A, Whitehouse R, Doussis-Anagnostopoulou I, Biddolph S, Tsiotos P, Mortensen N, Gatter KC, Harris AL. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer. Br J Cancer 1998;77:1864-9. [PMID: 9667660 DOI: 10.1038/bjc.1998.310] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 270 |
Kressner U, Glimelius B, Bergström R, Påhlman L, Larsson A, Lindmark G. Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer. Br J Cancer 1998;77:1848-51. [PMID: 9667657 DOI: 10.1038/bjc.1998.307] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 271 |
Yook JI, Kim J. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncol 1998;34:198-203. [PMID: 9692054 DOI: 10.1016/s1368-8375(97)00091-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 272 |
Murti PR, Warnakulasuriya KA, Johnson NW, Bhonsle RB, Gupta PC, Daftary DK, Mehta FS. p53 expression in oral precancer as a marker for malignant potential. J Oral Pathol Med 1998;27:191-6. [PMID: 9682980 DOI: 10.1111/j.1600-0714.1998.tb01940.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 273 |
Sakai A, Oda K, Asaoku H, Shintaku S, Hoshino S, Okita H, Kimura A. Expressions of p53 and PCNA do not correlate with the international index or early response to chemotherapy in non-Hodgkin's lymphoma. Am J Hematol 1998;58:42-8. [PMID: 9590148 DOI: 10.1002/(sici)1096-8652(199805)58:1<42::aid-ajh8>3.0.co;2-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 274 |
Kyokane K, Ito M, Sato Y, Ina K, Ando T, Kusugami K. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia. J Pathol 1998;184:382-9. [PMID: 9664903 DOI: 10.1002/(SICI)1096-9896(199804)184:4<382::AID-PATH1232>3.0.CO;2-F] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 275 |
Wiggenraad R, Tamminga R, Blok P, Rouse R, Hermans J. The prognostic significance of p53 expression for survival and local control in rectal carcinoma treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1998;41:29-35. [PMID: 9588914 DOI: 10.1016/s0360-3016(98)00043-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 276 |
Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, van der Waal I. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 1998;184:360-8. [PMID: 9664901 DOI: 10.1002/(SICI)1096-9896(199804)184:4<360::AID-PATH1263>3.0.CO;2-H] [Cited by in Crossref: 130] [Cited by in F6Publishing: 138] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 277 |
Gulley ML, Burton MP, Allred DC, Nicholls JM, Amin MB, Ro JY, Schneider BG. Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. Hum Pathol 1998;29:252-9. [PMID: 9496828 DOI: 10.1016/s0046-8177(98)90044-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 278 |
Fang SY, Yan JJ, Ohyama M. Immunohistochemistry of p53 in sinonasal inverted papilloma and associated squamous cell carcinoma. Am J Rhinol 1998;12:119-24. [PMID: 9578930 DOI: 10.2500/105065898781390235] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 279 |
Forster S, Sattler HP, Hack M, Romanakis K, Rohde V, Seitz G, Wullich B. Microsatellite instability in sporadic carcinomas of the proximal colon: association with diploid DNA content, negative protein expression of p53, and distinct histomorphologic features. Surgery. 1998;123:13-18. [PMID: 9457218 DOI: 10.1016/s0039-6060(98)70223-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 280 |
Polkowski W, Baak JP, van Lanschot JJ, Meijer GA, Schuurmans LT, Ten Kate FJ, Obertop H, Offerhaus GJ. Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation. J Pathol 1998;184:161-8. [PMID: 9602707 DOI: 10.1002/(SICI)1096-9896(199802)184:2<161::AID-PATH971>3.0.CO;2-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 281 |
Wilentz RE, Slebos RJC, Hruban RH. Screening for Pancreatic Cancer Using Techniques to Detect Altered Gene Products. Pancreatic Cancer 1998. [DOI: 10.1007/978-1-4612-1810-4_6] [Reference Citation Analysis]
|
| 282 |
Formenti SC, Dunnington G, Uzieli B, Lenz H, Keren-Rosenberg S, Silberman H, Spicer D, Denk M, Leichman G, Groshen S, Watkins K, Muggia F, Florentine B, Press M, Danenberg K, Danenberg P. Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapy. Int J Radiat Oncol Biol Phys 1997;39:1059-68. [PMID: 9392545 DOI: 10.1016/s0360-3016(97)00506-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 283 |
Würl P, Taubert H, Meye A, Berger D, Lautenschläger C, Holzhausen HJ, Schmidt H, Kalthoff H, Rath FW, Dralle H. Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies. J Cancer Res Clin Oncol 1997;123:502-8. [PMID: 9341900 DOI: 10.1007/BF01192205] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 284 |
Schlamp CL, Poulsen GL, Nork TM, Nickells RW. Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells. J Natl Cancer Inst 1997;89:1530-6. [PMID: 9337350 DOI: 10.1093/jnci/89.20.1530] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 285 |
Seki A, Kodama J, Miyagi Y, Kamimura S, Yoshinouchi M, Kudo T. Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas. Int J Cancer 1997;73:33-7. [PMID: 9334806 DOI: 10.1002/(sici)1097-0215(19970926)73:1<33::aid-ijc6>3.0.co;2-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 286 |
Saegusa M, Okayasu I. Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findings. J Cancer Res Clin Oncol 1997;123:429-34. [PMID: 9292705 DOI: 10.1007/BF01372546] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 287 |
Cohen PA, Mak KM, Rosman AS, Kessova I, Mishin VM, Koivisto T, Lieber CS. Immunohistochemical Determination of Hepatic Cytochrome P-4502E1 in Formalin-Fixed, Paraffin-Embedded Sections. Alcoholism Clin Exp Res 1997;21:1057-62. [DOI: 10.1111/j.1530-0277.1997.tb04254.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 288 |
Langlois NE, Lamb J, Eremin O, Heys SD. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J Pathol 1997;182:392-7. [PMID: 9306959 DOI: 10.1002/(SICI)1096-9896(199708)182:4<392::AID-PATH874>3.0.CO;2-G] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 289 |
Itoi T, Watanabe H, Yoshida M, Ajioka Y, Nishikura K, Saito T. Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas. Pathol Int 1997;47:525-30. [PMID: 9293532 DOI: 10.1111/j.1440-1827.1997.tb04535.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 290 |
Oka M, Kounoura K, Narasaki F, Sakamoto A, Fukuda M, Matsuo I, Ikeda K, Tsurutani J, Ikuno N, Omagari K, Mizuta Y, Soda H, Gudas JM, Kohno S. P-glycoprotein is positively correlated with p53 protein accumulation in human colorectal cancers. Jpn J Cancer Res 1997;88:738-42. [PMID: 9330605 DOI: 10.1111/j.1349-7006.1997.tb00445.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 291 |
Manne U, Myers RB, Moron C, Poczatek RB, Dillard S, Weiss H, Brown D, Srivastava S, Grizzle WE. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 1997;74:346-58. [PMID: 9221816 DOI: 10.1002/(sici)1097-0215(19970620)74:3<346::aid-ijc19>3.0.co;2-9] [Cited by in Crossref: 107] [Cited by in F6Publishing: 121] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 292 |
Mottaz AE, Markwalder R, Fey MF, Klima I, Merz VW, Thalmann GN, Ball RK, Studer UE. Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations. Prostate 1997;31:209-15. [PMID: 9180930 DOI: 10.1002/(sici)1097-0045(19970601)31:4<209::aid-pros1>3.0.co;2-f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 293 |
Gibson GE, O'Grady A, Kay EW, Leader M, Murphy GM. p53 tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients. J Am Acad Dermatol 1997;36:924-31. [PMID: 9204056 DOI: 10.1016/s0190-9622(97)80274-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 294 |
Ishida M, Gomyo Y, Ohfuji S, Ikeda M, Kawasaki H, Ito H. Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric intestinal-type carcinomas in vivo. Jpn J Cancer Res 1997;88:468-75. [PMID: 9247603 DOI: 10.1111/j.1349-7006.1997.tb00405.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 295 |
Zhu QR, White FH, Tipoe GL. p53 oncoprotein accumulation in adenoid cystic carcinoma of parotid and palatine salivary glands. Pathology 1997;29:154-8. [PMID: 9213334 DOI: 10.1080/00313029700169784] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 296 |
Lonardo F, Ueda T, Huvos AG, Healey J, Ladanyi M. p53 and MDM2 alterations in osteosarcomas: Correlation with clinicopathologic features and proliferative rate. Cancer 1997;79:1541-7. [DOI: 10.1002/(sici)1097-0142(19970415)79:8<1541::aid-cncr15>3.0.co;2-y] [Cited by in Crossref: 98] [Cited by in F6Publishing: 103] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 297 |
Kang M, Mitomi H, Sada M, Tokumitsu Y, Takahashi Y, Igarashi M, Katsumata T, Okayasu I. Ki-67, p53, and Bcl-2 expression of serrated adenomas of the colon. Am J Surg Pathol 1997;21:417-23. [PMID: 9130988 DOI: 10.1097/00000478-199704000-00007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 298 |
Lise M, Loda M, Fiorentino M, Mercurio AM, Summerhayes IC, Lavin PT, Jessup JM. Association between sucrase-isomaltase and p53 expression in colorectal cancer. Ann Surg Oncol 1997;4:176-83. [PMID: 9084856 DOI: 10.1007/BF02303802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 299 |
Shivapurkar N, Nikula KJ, Tanaka T, Tang ZC, Alabaster O. Absence of p53 gene mutations in rat colon carcinomas induced through the synergistic interaction between methylazoxymethanol and X-irradiation. Cancer Lett 1997;113:9-16. [PMID: 9065795 DOI: 10.1016/s0304-3835(96)04551-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 300 |
Pereira H, Silva S, Julião R, Garcia P, Perpétua F. Prognostic markers for colorectal cancer: expression of P53 and BCL2. World J Surg 1997;21:210-3. [PMID: 8995081 DOI: 10.1007/s002689900218] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 301 |
Cohn KH, Ornstein DL, Wang F, Lapaix FD, Phipps K, Edelsberg C, Zuna R, Mott LA, Dunn JL. The significance of allelic deletions and aneuploidy in colorectal carcinoma: Results of a 5-year follow-up study. Cancer 1997;79:233-44. [DOI: 10.1002/(sici)1097-0142(19970115)79:2<233::aid-cncr6>3.0.co;2-l] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 302 |
Ayan I, Dŏgan O, Kebudi R, Bavbek B, Alatli C, Dervişoğlu S, Dişçi R, Demiryont M. Immunohistochemical detection of p53 protein in rhabdomyosarcoma: association with clinicopathological features and outcome. J Pediatr Hematol Oncol 1997;19:48-53. [PMID: 9065719 DOI: 10.1097/00043426-199701000-00007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 303 |
Ito H, Ishida M, Ohfuji S, Osaki M, Hayashi H, Tatebe S. Stomach Cancer and Apoptosis: A Review. In: Tahara E, editor. Molecular Pathology of Gastroenterological Cancer. Tokyo: Springer Japan; 1997. pp. 81-92. [DOI: 10.1007/978-4-431-65915-0_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 304 |
Poller DN, Baxter KJ, Shepherd NA. p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 1997;75:87-93. [PMID: 9000603 DOI: 10.1038/bjc.1997.14] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 305 |
Visscher DW, Sarkar FH, Crissman JD. Molecular genetic analysis in the pathologic evaluation of solid tumors: Theory and practice. J Clin Lab Anal 1997;11:10-6. [DOI: 10.1002/(sici)1098-2825(1997)11:1<10::aid-jcla3>3.0.co;2-o] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 306 |
Hollstein M, Soussi T, Thomas G, von Brevern MC, Bartsch. P53 gene alterations in human tumors: perspectives for cancer control. Recent Results Cancer Res 1997;143:369-89. [PMID: 8912433 DOI: 10.1007/978-3-642-60393-8_26] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 307 |
Hino N, Kondo K, Miyoshi T, Uyama T, Monden Y. High frequency of p53 protein expression in thymic carcinoma but not in thymoma. Br J Cancer 1997;76:1361-6. [PMID: 9374384 DOI: 10.1038/bjc.1997.561] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 308 |
Burkhard FC, Markwalder R, Thalmann GN, Studer UE. Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer? Urol Res 1997;25 Suppl 1:S31-5. [PMID: 9079754 DOI: 10.1007/BF00942045] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 309 |
Debuire B. Protéine P53: applications cliniques. Revue Française des Laboratoires 1996;1996:59-63. [DOI: 10.1016/s0338-9898(96)80030-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 310 |
Biernat W, Kordek R, Liberski PP, Woźniak L. Carcinosarcoma of the skin. Case report and literature review. Am J Dermatopathol 1996;18:614-9. [PMID: 8989936 DOI: 10.1097/00000372-199612000-00012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 311 |
Matsuda K, Watanabe H, Ajioka Y, Kobayashi M, Saito H, Sasaki M, Yasuda K, Kuwabara A, Nishikura K, Muto T. Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium. J Gastroenterol 1996;31:860-7. [PMID: 9027653 DOI: 10.1007/BF02358616] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 312 |
Leahy DT, Salman R, Mulcahy H, Sheahan K, O'Donoghue DP, Parfrey NA. Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis. J Pathol 1996;180:364-70. [PMID: 9014855 DOI: 10.1002/(SICI)1096-9896(199612)180:4<364::AID-PATH683>3.0.CO;2-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 313 |
Hunt CR, Hale RJ, Buckley CH, Hunt J. p53 expression in carcinoma of the cervix. J Clin Pathol 1996;49:971-4. [PMID: 9038732 DOI: 10.1136/jcp.49.12.971] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 314 |
Miturski R, Semczuk A, Jakowicki J. Simultaneous expression of the ras p21 and p53 proteins in human endometrial carcinomas. Acta Histochem 1996;98:411-8. [PMID: 8960305 DOI: 10.1016/S0065-1281(96)80008-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 315 |
Moskaluk CA, Heitmiller R, Zahurak M, Schwab D, Sidransky D, Hamilton SR. p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction. Hum Pathol 1996;27:1211-20. [PMID: 8912833 DOI: 10.1016/s0046-8177(96)90317-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 316 |
Shiina H, Igawa M, Nagami H, Yagi H, Urakami S, Yoneda T, Shirakawa H, Ishibe T, Kawanishi M. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder. Cancer 1996;78:1762-74. [PMID: 8859190 DOI: 10.1002/(sici)1097-0142(19961015)78:8<1762::aid-cncr17>3.0.co;2-w] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 317 |
Apakama I, Robinson MC, Walter NM, Charlton RG, Royds JA, Fuller CE, Neal DE, Hamdy FC. bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer. Br J Cancer 1996;74:1258-62. [PMID: 8883414 DOI: 10.1038/bjc.1996.526] [Cited by in Crossref: 88] [Cited by in F6Publishing: 94] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 318 |
Visscher DW, Sarkar FH, Shimoyama RK, Crissman JD. Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma. Diagn Mol Pathol 1996;5:187-93. [PMID: 8866232 DOI: 10.1097/00019606-199609000-00007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 319 |
Talve L, Kainu J, Collan Y, Ekfors T. Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin. Pathol Res Pract 1996;192:825-33. [PMID: 8897518 DOI: 10.1016/S0344-0338(96)80056-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 320 |
Ilyas M, Tomlinson IP, Novelli MR, Hanby A, Bodmer WF, Talbot IC. Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability. J Pathol 1996;179:370-5. [PMID: 8869282 DOI: 10.1002/(SICI)1096-9896(199608)179:4<370::AID-PATH627>3.0.CO;2-N] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 321 |
Cheah PL, Looi LM. Implications of p53 protein expression in clear cell sarcoma of the kidney. Pathology 1996;28:229-31. [PMID: 8912350 DOI: 10.1080/00313029600169034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 322 |
Kushima R, Müller W, Stolte M, Borchard F. Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: possible sequences of p53 alteration in stomach carcinogenesis. Virchows Arch 1996;428:223-7. [PMID: 8764930 DOI: 10.1007/BF00196694] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 323 |
Slebos RJ, Baas IO, Clement M, Polak M, Mulder JW, van den Berg FM, Hamilton SR, Offerhaus GJ. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma. Br J Cancer 1996;74:165-71. [PMID: 8688317 DOI: 10.1038/bjc.1996.333] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 324 |
Rees JL, Healy E. Molecular genetic approaches to non-melanoma and melanoma skin cancer. Clin Exp Dermatol 1996;21:253-62. [PMID: 8959894 DOI: 10.1111/j.1365-2230.1996.tb00089.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 325 |
Saegusa M, Takano Y, Kamata Y, Okayasu J. Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas. J Cancer Res Clin Oncol 1996;122:427-32. [PMID: 8690754 DOI: 10.1007/BF01212883] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 326 |
Lim BH, Soong R, Grieu F, Robbins PD, House AK, Iacopetta BJ. p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma. Int J Cancer 1996;69:200-4. [PMID: 8682588 DOI: 10.1002/(SICI)1097-0215(19960621)69:3<200::AID-IJC9>3.0.CO;2-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 327 |
Hanski C, Tiecke F, Hummel M, Hanski ML, Ogorek D, Rolfs A, Schmitt-Gräff A, Stein H, Riecken EO. Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas. Cancer Lett 1996;103:163-70. [PMID: 8635153 DOI: 10.1016/0304-3835(96)04208-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 328 |
Wertz IE, Deitch AD, Gumerlock PH, Gandour-Edwards R, Chi SG, de Vere White RW. Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues. Hum Pathol 1996;27:573-80. [PMID: 8666367 DOI: 10.1016/s0046-8177(96)90164-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 329 |
Kanoko M, Ueda M, Nagano T, Ichihashi M. Expression of p53 protein in melanoma progression. J Dermatol Sci 1996;12:97-103. [PMID: 8814540 DOI: 10.1016/0923-1811(95)00465-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 330 |
Itoi T, Watanabe H, Ajioka Y, Oohashi Y, Takel K, Nishikura K, Nakamura Y, Horil A, Saito T. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Pathol Int 1996;46:333-40. [PMID: 8809879 DOI: 10.1111/j.1440-1827.1996.tb03618.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 331 |
Kaklamanis L, Savage A, Mortensen N, Tsiotos P, Doussis-Anagnostopoulou I, Biddolph S, Whitehouse R, Harris AL, Gatter KC. Early expression of bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia. J Pathol 1996;179:10-4. [PMID: 8691332 DOI: 10.1002/(SICI)1096-9896(199605)179:1<10::AID-PATH540>3.0.CO;2-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 332 |
Li TJ, Browne RM, Prime SS, Paterson IC, Matthews JB. p53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med 1996;25:249-55. [PMID: 8835823 DOI: 10.1111/j.1600-0714.1996.tb01380.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 333 |
Bocker T, Schlegel J, Kullmann F, Stumm G, Zirngibl H, Epplen JT, Rüschoff J. Genomic instability in colorectal carcinomas: comparison of different evaluation methods and their biological significance. J Pathol 1996;179:15-9. [PMID: 8691338 DOI: 10.1002/(SICI)1096-9896(199605)179:1<15::AID-PATH553>3.0.CO;2-N] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 334 |
Baretton GB, Vogt M, Müller C, Diebold J, Schneiderbanger K, Schmidt M, Löhrs U. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II). Scand J Gastroenterol 1996;31:481-9. [PMID: 8734346 DOI: 10.3109/00365529609006769] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 335 |
Baas IO, Offerhaus JA, El-Deiry WS, Wu TC, Hutchins GM, Kasper EK, Baughman KL, Baumgartner WA, Chiou CJ, Hayward GS, Hruban RH. The WAF1-mediated p53 growth-suppressor pathway is intact in the coronary arteries of heart transplant recipients. Hum Pathol 1996;27:324-9. [PMID: 8617473 DOI: 10.1016/s0046-8177(96)90103-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 336 |
Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 1996;27:360-5. [PMID: 8617479 DOI: 10.1016/s0046-8177(96)90109-4] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 337 |
Müller W, Borchard F. Prognostic influence of p53 expression in gastric cancer. J Pathol 1996;178:255-8. [PMID: 8778328 DOI: 10.1002/(SICI)1096-9896(199603)178:3<255::AID-PATH468>3.0.CO;2-V] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 338 |
Sagartz JE, Bodley WL, Gamblin RM, Couto CG, Tierney LA, Capen CC. p53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Vet Pathol 1996;33:213-21. [PMID: 8801715 DOI: 10.1177/030098589603300211] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 339 |
Baas IO, van den Berg FM, Mulder JW, Clement MJ, Slebos RJ, Hamilton SR, Offerhaus GJ. Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms. J Pathol 1996;178:264-7. [PMID: 8778330 DOI: 10.1002/(SICI)1096-9896(199603)178:3<264::AID-PATH485>3.0.CO;2-#] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 340 |
Rizzi PM, Ryder SD, Portmann B, Ramage JK, Naoumov NV, Williams R. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis. Gut 1996;38:265-8. [PMID: 8801209 DOI: 10.1136/gut.38.2.265] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 341 |
Poljak M, Cerar A, Orlowska J. p53 protein expression in esophageal squamous cell papillomas: a study of 36 lesions. Scand J Gastroenterol 1996;31:10-3. [PMID: 8927934 DOI: 10.3109/00365529609031620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 342 |
Shi S, Gu J, Kalra KL, Chen T, Cote RJ, Taylor CR. Antigen Retrieval Technique: A Novel Approach to Immunohistochemistry on Routinely Processed Tissue Sections. Analytical Morphology 1996. [DOI: 10.1007/978-1-4612-4166-9_1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 343 |
Horne GM, Anderson JJ, Tiniakos DG, McIntosh GG, Thomas MD, Angus B, Henry JA, Lennard TW, Horne CH. p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry. Br J Cancer 1996;73:29-35. [PMID: 8554979 DOI: 10.1038/bjc.1996.6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 344 |
Rüschoff J, Bocker T, Vogel P, Schlegel J. Prognostic significance of molecular biological and immunohistological parameters in gastrointestinal carcinomas. Recent Results Cancer Res 1996;142:73-88. [PMID: 8893336 DOI: 10.1007/978-3-642-80035-1_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 345 |
Dalquen P, Sauter G, Torhorst J, Schultheiss E, Jordan P, Lehmann S, Solèr M, Stulz P, Mihatsch MJ, Gudat F. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma. J Pathol 1996;178:53-8. [PMID: 8778317 DOI: 10.1002/(SICI)1096-9896(199601)178:1<53::AID-PATH415>3.0.CO;2-T] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 346 |
Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, Akie K, Kawakami Y. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer. Cancer 1995;76:2457-63. [PMID: 8625071 DOI: 10.1002/1097-0142(19951215)76:12<2457::aid-cncr2820761209>3.0.co;2-x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 347 |
Leong AS, Robbins P, Spagnolo DV. Tumor genes and their proteins in cytologic and surgical specimens: relevance and detection systems. Diagn Cytopathol 1995;13:411-22. [PMID: 8834315 DOI: 10.1002/dc.2840130509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 348 |
Jackson PA, Green MA, Pouli A, Hubbard R, Marks CG, Cook MG. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum. J Clin Pathol 1995;48:1098-101. [PMID: 8567994 DOI: 10.1136/jcp.48.12.1098] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 349 |
Karamitopoulou E, Perentes E, Diamantis I, Vogt U, Wegmann W. p53 protein expression in colorectal adenomas: an immunohistochemical study using an antigen retrieval system. Histopathology 1995;27:517-23. [PMID: 8838331 DOI: 10.1111/j.1365-2559.1995.tb00322.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 350 |
Bremer GL, Tieboschb AT, van der Putten HW, de Haan J, Arends JW. p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis. Eur J Obstet Gynecol Reprod Biol 1995;63:55-9. [PMID: 8674566 DOI: 10.1016/0301-2115(95)02225-v] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 351 |
Mighell A. PCNA and p53. Eur J Cancer B Oral Oncol 1995;31B:403-4. [PMID: 8746274 DOI: 10.1016/0964-1955(95)00037-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 352 |
Healy E, Angus B, Lawrence CM, Rees JL. Prognostic value of Ki67 antigen expression in basal cell carcinomas. Br J Dermatol 1995;133:737-41. [PMID: 8555026 DOI: 10.1111/j.1365-2133.1995.tb02748.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 353 |
Dowell SP. p53 immunocytochemical staining in diagnostic cytopathology: the relevance of the proportion of positive cells. Cytopathology 1995;6:361-2. [PMID: 8785377 DOI: 10.1111/j.1365-2303.1995.tb00585.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 354 |
Taubert H, Würl P, Meye A, Berger D, Thamm B, Neumann K, Hinze R, Schmidt H, Rath FW. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas. Cancer 1995;76:1187-96. [PMID: 8630896 DOI: 10.1002/1097-0142(19951001)76:7<1187::aid-cncr2820760714>3.0.co;2-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 355 |
Gabbert HE, Müller W, Schneiders A, Meier S, Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995;76:720-6. [DOI: 10.1002/1097-0142(19950901)76:5<720::aid-cncr2820760503>3.0.co;2-e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 356 |
Gabbert HE, Müller W, Schneiders A, Meier S, Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995;76:720-6. [PMID: 8625172 DOI: 10.1002/1097-0142(19950901)76:5<720::aid-cncr2820760503>3.0.co;2-e] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 357 |
Yang P, Hirose T, Hasegawa T, Seki K, Sano T, Hizawa K. Prognostic implication of the p53 protein and Ki-67 antigen immunohistochemistry in malignant fibrous histiocytoma. Cancer 1995;76:618-25. [PMID: 8625155 DOI: 10.1002/1097-0142(19950815)76:4<618::aid-cncr2820760412>3.0.co;2-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 358 |
Saegusa M, Takano Y, Wakabayashi T, Okayasu I. Apoptosis in gastric carcinomas and its association with cell proliferation and differentiation. Jpn J Cancer Res 1995;86:743-8. [PMID: 7559097 DOI: 10.1111/j.1349-7006.1995.tb02463.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 359 |
Danks RA, Chopra G, Gonzales MF, Orian JM, Kaye AH. Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma. Neurosurgery 1995;37:246-54. [PMID: 7477776 DOI: 10.1227/00006123-199508000-00009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 360 |
Danks RA, Chopra G, Gonzales MF, Orian JM, Kaye AH. Aberrant p53 Expression Does Not Correlate with the Prognosis in Anaplastic Astrocytoma: . Neurosurgery 1995;37:246???254. [DOI: 10.1097/00006123-199508000-00009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 361 |
Craanen ME, Blok P, Dekker W, Offerhaus GJ, Tytgat GN. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 1995;36:848-52. [PMID: 7615272 DOI: 10.1136/gut.36.6.848] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 362 |
Mulder JW, Baas IO, Polak MM, Goodman SN, Offerhaus GJ. Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer 1995;71:1257-62. [PMID: 7779721 DOI: 10.1038/bjc.1995.243] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 363 |
Saegusa M, Takano Y, Okayasu I. Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. J Cancer Res Clin Oncol 1995;121:357-63. [PMID: 7797601 DOI: 10.1007/BF01225688] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 364 |
Polkowski W, van Lanschot JJ, Ten Kate FJ, Baak JP, Tytgat GN, Obertop H, Voorn WJ, Offerhaus GJ. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol 1995;4:163-71. [PMID: 7582189 DOI: 10.1016/s0960-7404(10)80021-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 365 |
Makris A, Powles TJ, Dowsett M, Allred C. p53 protein overexpression and chemosensitivity in breast cancer. Lancet 1995;345:1181-2. [PMID: 7723571 DOI: 10.1016/s0140-6736(95)91014-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 366 |
Biernat W, Kordek R, Woźniak L. Over-expression of p53 protein as an indicator of the malignant transformation in spiradenoma. Histopathology 1995;26:439-43. [PMID: 7657312 DOI: 10.1111/j.1365-2559.1995.tb00251.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 367 |
Piffko J, Bankfalvi A, Ofner D, Joos U, Böcker W, Schmid KW. Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval. J Pathol 1995;176:69-75. [PMID: 7616359 DOI: 10.1002/path.1711760111] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 368 |
Costa A, Marasca R, Valentinis B, Savarino M, Faranda A, Silvestrini R, Torelli G. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. J Pathol 1995;176:45-53. [PMID: 7616356 DOI: 10.1002/path.1711760108] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 369 |
Miyaki M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Konishi M. Familial polyposis: recent advances. Crit Rev Oncol Hematol 1995;19:1-31. [PMID: 7741978 DOI: 10.1016/1040-8428(94)00129-h] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 370 |
Wang DG, Johnston CF, Anderson N, Sloan JM, Buchanan KD. Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis. J Pathol 1995;175:397-401. [PMID: 7790993 DOI: 10.1002/path.1711750406] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 371 |
O'Dowd G, Gosney JR. Absence of overexpression of p53 protein by intestinal carcinoid tumours. J Pathol 1995;175:403-4. [PMID: 7790994 DOI: 10.1002/path.1711750407] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 372 |
Piris MA, Villuendas R, Martinez JC, Sanchez-Beato M, Orradre JL, Mateo MS, Martinez P. p53 expression in non-Hodgkin's lymphomas: a marker of p53 inactivation? Leuk Lymphoma 1995;17:35-42. [PMID: 7773162 DOI: 10.3109/10428199509051701] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 373 |
McGregor JM, Dublin EA, Levison DA, MacDonald DM, Smith NP, Whittaker S. p53 immunoreactivity is uncommon in primary cutaneous lymphoma. Br J Dermatol 1995;132:353-8. [PMID: 7718450 DOI: 10.1111/j.1365-2133.1995.tb08667.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 374 |
van Es JM, Polak MM, van den Berg FM, Ramsoekh TB, Craanen ME, Hruban RH, Offerhaus GJ. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product. J Clin Pathol 1995;48:218-22. [PMID: 7730480 DOI: 10.1136/jcp.48.3.218] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 375 |
Chetty R, Gatter K, O'leary V. Immunocytochemistry as a diagnostic tool. Current Diagnostic Pathology 1995;2:38-45. [DOI: 10.1016/s0968-6053(00)80018-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 376 |
Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol 1995;175:175-80. [PMID: 7738712 DOI: 10.1002/path.1711750204] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 377 |
Xerri L, Parc P, Bouabdallah R, Camerlo J, Hassoun J. PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease. J Pathol 1995;175:189-94. [PMID: 7738714 DOI: 10.1002/path.1711750206] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 378 |
Carder PJ, Cripps KJ, Morris R, Collins S, White S, Bird CC, Wyllie AH. Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma. Br J Cancer 1995;71:215-8. [PMID: 7841032 DOI: 10.1038/bjc.1995.46] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 379 |
MacGrogan G, Bonichon F, de Mascarel I, Trojani M, Durand M, Avril A, Coindre JM. Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases. Breast Cancer Res Treat 1995;36:71-81. [PMID: 7579509 DOI: 10.1007/BF00690187] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 380 |
Mulder JW, Wielenga VJ, Polak MM, van den Berg FM, Adolf GR, Herrlich P, Pals ST, Offerhaus GJ. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut 1995;36:76-80. [PMID: 7534253 DOI: 10.1136/gut.36.1.76] [Cited by in Crossref: 38] [Cited by in F6Publishing: 50] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 381 |
Diamandis EP, Levesque MA. Assessment of p53 overexpression by non-immunohistochemical methods. J Pathol 1995;175:93-5. [PMID: 7891232 DOI: 10.1002/path.1711750114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 382 |
Dix BR, Robbins P, Soong R, Jenner D, House AK, Iacopetta BJ. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer 1994;59:747-51. [PMID: 7989112 DOI: 10.1002/ijc.2910590606] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 383 |
Ootsuyama A, Makino H, Nagao M, Ochiai A, Yamauchi Y, Tanooka H. Frequent p53 mutation in mouse tumors induced by repeated beta-irradiation. Mol Carcinog 1994;11:236-42. [PMID: 7999265 DOI: 10.1002/mc.2940110409] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 384 |
Takata M, Matsui Y. Proliferating cell nuclear antigen (PCNA) and p53 protein expression in Bowen's disease. J Dermatol 1994;21:947-52. [PMID: 7868767 DOI: 10.1111/j.1346-8138.1994.tb03317.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 385 |
Dix B, Robbins P, Carrello S, House A, Iacopetta B. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 1994;70:585-90. [PMID: 7917901 DOI: 10.1038/bjc.1994.355] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 386 |
Fontanini G, Vignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA, Basolo F, Pingitore R, Bevilacqua G. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J Pathol 1994;174:23-31. [PMID: 7965400 DOI: 10.1002/path.1711740105] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 387 |
Symmans PJ, Linehan JM, Brito MJ, Filipe MI. p53 expression in Barrett's oesophagus, dysplasia, and adenocarcinoma using antibody DO-7. J Pathol 1994;173:221-6. [PMID: 7931842 DOI: 10.1002/path.1711730304] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 388 |
Dowell SP, Hall PA. The clinical relevance of the p53 tumour suppressor gene. Cytopathology 1994;5:133-45. [PMID: 7919056 DOI: 10.1111/j.1365-2303.1994.tb00409.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 389 |
Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! J Pathol 1994;172:1-4. [PMID: 7931821 DOI: 10.1002/path.1711720103] [Cited by in Crossref: 425] [Cited by in F6Publishing: 445] [Article Influence: 14.7] [Reference Citation Analysis]
|
